Cutlip, DE, Jauhar, R, Meraj P, Garratt KN, Novack V, Novack L, Maillard L, Erglis A, Stoler R, Barakat M, Silber S. for the PzF SHIELD Trial Investigators Five-Year Clinical Outcomes of the COBRA Polyzene F NanoCoated Coronary Stent System Cardiovasc Revasc Med 2022 Vol. 41 Pages 76-80 your personal reprint

Silber S. [Determination of the individual risk of a heart attack, stroke or cardiovascular death in apparently healthy persons] MMW Fortschr Med. 2022;164:32-36 (in German language) your personal reprint

Silber S. Editorial [Prognosis of Heart Failure Worse than Cancer] MMW Fortschr Med. 2022;164:5 (in German language) your personal reprint

Silber S. [The new ESC guideline for heart failure therapy: What has changed for general practice?] MMW Fortschr Med. 2022;164:40-43 (in German language) your personal reprint

Keller, M, Silber S. [Amyloidosis of the heart: When do general practitioners have to think about it?] MMW Fortschr Med. 2021;163:54-56 (in German language) your personal reprint

Kelbaek H, Yeh RW, Engstrom T, Neumann FJ, Serruys PW, Windecker S, Belardi J, Qiao S, Xu B, Liu M, Silber S. Five-year clinical outcomes for the Resolute zotarolimus-eluting stent in total coronary occlusions EuroIntervention. 2021, 16: 1326 -1332 your personal reprint

Cortes C, Chu M, Schincariol M, Martinez-Hervas Alonso MA, Reisbeck B, Zhang R, Murasato Y, Chen S, Lavarra F, Tu S, Silber S, Gutierrez-Chico JL. Identification of the type of stent with three-dimensional optical coherence tomography: the SPQR study EuroIntervention. 2021, 17: e140 - e148 your personal reprint

Cortes C, Johnson TW, Silber S, Buszman PP, Poerner TC, Lavarra F, Ibanez B, Kim Y, Mischke K, Jaguszewski M, Gutierrez-Chico JL. ISCHEMIA trial: The long-awaited evidence to confirm our prejudices Cardiol J. 2020;27:336-341 your personal reprint

Bengel FM, Burchert W, Dörr R, Hacker M, Kaufmann P, Rischpler C, Schäfer W, Schäfers M, Silber S, Zimmermann R, Buechel RR [The Role of Nuclear Cardiology in Cardiac Amyloidosis] Der Kardiologe, 2020, 14: 42-45 (in German language) your personal reprint Reply: Frey N, Bauersachs J, v. Knobelsdorff F, Bönner F, Yilmaz A Kommentierungen zum Positionspapier der DGK Der Kardiologe, 2020, 14: 46-50 (in German language) your personal reprint

Figulla HR, Lauten A, Maier LS, Sechtem U, Silber S, Thiele H. [Percutaneous Coronary Intervention in Stable Coronary Heart Disease - Is Less More?] Deutsches Arzteblatt international. 2020;117:137-144 (in German language) your personal reprint

Haude M, Lee SWL, Worthley SG, Silber S, Verheye S, Rosli MA, Botelho R, Sim KH, Abizaid A, Mehran R, Investigators RT. The REMEDEE trial: 5-Year results on a novel combined sirolimus-eluting and endothelial progenitor cells capturing stent Catheter Cardiovasc Interv. 2020;95:1076-1084 your personal reprint

Silber S. [ESC guidelines 2019 on chronic coronary syndrome (CCS, previously “stable coronary artery disease”) : What is new? What is particularly important?] Herz. 2019;44:676-683 (in German language) your personal reprint

Silber S. [The new Disease Management Program (DMP) for patients with chronic systolic heart failure in Germany: Goals and limitations] MMW Fortschr Med. 2019;161:40-44 (in German language) your personal reprint

Siontis GC, Branca M, Serruys P, Silber S, Raber L, Pilgrim T, Valgimigli M, Heg D, Windecker S, Hunziker L. Impact of left ventricular function on clinical outcomes among patients with coronary artery disease European Journal of Preventive Cardiology. 2019;26:1273-1284 your personal reprint

Garcia-Garcia HM, McFadden EP, von Birgelen C, Rademaker-Havinga T, Spitzer E, Kleiman NS, Cohen DJ, Kennedy KF, Camenzind E, Mauri L, Steg PG, Wijns W, Silber S, van Es GA, Serruys PW, Windecker S, Cutlip D, Vranckx P. Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention JACC Cardiovasc Interv. 2019;12:1954-1962 your personal reprint

Grammer TB, Dressel A, Gergei I, Kleber ME, Laufs U, Scharnagl H, Nixdorff U, Klotsche J, Pieper L, Pittrow D, Silber S, Wittchen HU, März W.: Cardiovascular risk algorithms in primary care: Results from the DETECT study. Sci Rep. 2019;9:1101 your personal reprint

Lindner O, Bauersachs J, Bengel FM, Burchert W, Vom Dahl J, Dorr R, Hacker M, Kelm M, Rassaf T, Rischpler C, Schafer W, Schafers MA, Silber S, Zimmermann R. [Policy paper nuclear cardiology - update 2018 - Current status of clinical practice] Kardiologe: 2018; 12: 303 - 311 und Nuklearmedizin. 2018; 57:146-152 (in German language) your personal reprint

Kische H, Hoyer J, Pieper L, Venz J, Klotsche J, Marz W, Koch-Gromus U, Pittrow D, Lehnert H, Silber S, Stalla GK, Zeiher AM, Wittchen HU, Haring R. Testosterone is not associated with traits of optimism or pessimism: Observational evidence from the prospective DETECT study. PLoS One. 2018;13:e0207870 your personal reprint

Boeckel JN, Palapies L, Klotsche J, Zeller T, von Jeinsen B, Perret MF, Kleinhaus SL, Pieper L, Tzikas S, Leistner D, Bickel C, Stalla GK, Lehner H, Lindahl B, Wittchen HU, Silber S, Baldus S, Maerz W, Dimmeler S, Blankenberg S, Münzel T, Zeiher AM, Keller T: Adjusted Troponin I for Improved Evaluation of Patients with Chest Pain Nature - Scientific Reports, 2018, 8:8087 your personal reprint

Kische H, Pieper L, Venz J, Klotsche J, Marz W, Koch-Gromus U, Pittrow D, Lehnert H, Silber S, Stalla GK, Zeiher AM, Wittchen HU, Haring R: Longitudinal change instead of baseline testosterone predicts depressive symptoms Psychoneuroendocrinology. 2018;89:7-12 your personal reprint

Silber S. Do you know your Risk of a Heart Attack ? Journal for Cardiology (Austria) (approved Reprint of the MMW publication) 2018, 25: 135-139 (in German language) your personal reprint

Silber S. Primary Prevention: Do you know your Risk of a Heart Attack ? Münchner Medizinische Wochenschrift, MMW, 2018, 160: 38-41 (in German language) your personal reprint References Cover Page: “Heart in Danger - Calculate your Risk”

Albus C, Barkhausen J, Fleck E, Haasenritter J, Lindner O, Silber S für die Leitliniengruppe NVL Chronische KHK Diagnosis of Chronic Coronary Heart Disease Clinical Guideline Deutsches Ärzteblatt, 2017; 114: 712–719 (in German language) your personal reprint Additional Material Deutsches Ärzteblatt, 2018; 115: 131–132 Discussion and Final Word (in German language) your personal reprint

Keller M, Silber S. Update Heart Attack: Warning Symptoms, Primary and Secondary Prevention Medical Journal 8/2017 (in German language) your personal reprint

Silber, S. [Suspected stable coronary artery disease - When should the general practitioner refer to a cardiologist for further evaluation and/or cardiac catheterization?] Verdacht auf stabile KHK: Wann zum Herzkatheter überweisen ? MMW - Fortschritte der Medizin, 2017; 159: 46-48 (in German language) your personal reprint

Silber, S. [Secondary prevention after myocardial infarction with prolonged dual anti-platelet therapy (DAPT). A new therapeutic concept] Thrombozytenhemmung doppelt und für drei zusätzliche Jahre ? MMW - Fortschritte der Medizin, 2017; 159: 49-52 (in German language) your personal reprint

Yeh RW, Silber S, Chen L, Chen S, Hiremath S, Neumann FJ, Qiao S, Saito S, Xu B, Yang Y, Mauri L. 5-Year Safety and Efficacy of Resolute Zotarolimus-Eluting Stent: The RESOLUTE Global Clinical Trial Program JACC Cardiovasc Interv. 2017;10:247-254 your personal reprint

Cutlip DE, Garratt KN, Novack V, Barakat M, Meraj P, Maillard L, Erglis A, Jauhar R, Popma JJ, Stoler R, Silber S 9-Month Clinical and Angiographic Outcomes of the COBRA Polyzene-F NanoCoated Coronary Stent System JACC Cardiovasc Interv. 2017;10:160-167 your personal reprint

Fajadet J, Neumann FJ, Hildick-Smith D, Petronio S, Zaman A, Spence M, Wohrle J, Elhadad S, Roberts D, Hovasse T, Valdes M, Silber S. Twelve-Month Results of A Prospective, Multicentre Trial to Assess the Everolimus-Eluting Coronary Stent System (Promus Element): The PLATINUM PLUS All Comers Randomised Trial. EuroIntervention. 2017;12:1595-1604 your personal reprint

Keller T, Boeckel JN, Gross S, Klotsche J, Palapies L, Leistner D, Pieper L, Stalla GK, Lehnert H, Silber S, Pittrow D, Maerz W, Dorr M, Wittchen HU, Baumeister SE, Volker U, Felix SB, Dimmeler S, Zeiher AM. Improved risk stratification in prevention by use of a panel of selected circulating microRNAs. Sci Rep. 2017;7:4511 your personal reprint

Di Mario C, Serruys PW, Silber S, Lu S, Wang W, Widimsky P, Xu B, Windecker S. Long-term outcomes after Resolute zotarolimus-eluting stent implantation in patients with ST-segment elevation acute myocardial infarction: insights from the RESOLUTE All Comers Trial and the RESOLUTE Global Clinical Trial Program. EuroIntervention, 2016;12:1207-1214 your personal reprint

Silber S, Witzenbichler B, Vester E. [Optimal Oral Platelet Inhibition in Patients after Acute Coronary Syndrome (ACS): When to begin ? which drug ? how long ?] Optimale orale Thrombozytenaggregationshemmung (TAH) bei Patienten mit und nach akutem Koronarsyndrom (ACS): Wann beginnen, womit und wie lange? Eine Therapieempfehlung des BIK - Berufsverband Interventioneller Kardiologen - e.V., Update, 3. Version, Fall 2016 (in German language) your personal reprint

Helms TM, Silber S, Schäfer A, Masuhr F, Palm F, Darius H, Schrör K, Bansch D, Bramlage P, Hankowitz J, Karle CA, Stargardt T, Weil J, Geller JC. [Consensus statement: Management of oral anticoagulation for stroke prevention in patients with nonvalvular atrial fibrillation] Konsensuspapier: Schlaganfallprophylaxe bei Patienten mit nichtvalvulärem Vorhofflimmern Herzschrittmachertherapie & Elektrophysiologie. 2016; 27:295-306 (in German language) your personal reprint

Pilgrim T, Vranckx P, Valgimigli M, Stefanini GG, Piccolo R, Rat J, Rothenbuhler M, Stortecky S, Raber L, Blochlinger S, Hunziker L, Silber S, Juni P, Serruys PW, Windecker S. Risk and timing of recurrent ischemic events among patients with stable ischemic heart disease, non-ST-segment elevation acute coronary syndrome, and ST-segment elevation myocardial infarction. Am Heart J. 2016;175:56-65 your personal reprint

Abdel-Wahab M, Neumann FJ, Serruys PW, Silber S, Leon M, Mauri L, Yeung A, Belardi JA, Widimsky P, Meredith I, Saito S, Richardt G. Incidence and predictors of unplanned non-target lesion revascularisation up to three years after drug-eluting stent implantation: insights from a pooled analysis of the RESOLUTE Global Clinical Trial Program EuroIntervention, 2016, 12:465-472 your personal reprint

Piccolo R, Franzone A, Koskinas KC, Raber L, Pilgrim T, Valgimigli M, Stortecky S, Rat-Wirtzler J, Silber S, Serruys PW, Juni P, Heg D, Windecker S. Effect of Diabetes Mellitus on Frequency of Adverse Events in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention. Am J Cardiol. 2016;118:345-352 your personal reprint

Styllou P, Silber S. A case report of the new PolyzeneTM-F COBRA PzFTM Nanocoated Coronary Stent System (NCS): Addressing an unmet clinical need Cardiovasc Revasc Med, 2016; 17:209-211 your personal reprint

Belardi J, Manoharan G, Albertal M, Widimsky P, Neumann FJ, Silber S, Leon MB, Saito S. The influence of age on clinical outcomes in patients treated with the resolute zotarolimus-eluting stent. Catheter Cardiovasc Interv. 2016;87:253-261 your personal reprint

Koskinas KC, Siontis GC, Piccolo R, Franzone A, Haynes A, Rat-Wirtzler J, Silber S, Serruys PW, Pilgrim T, Raber L, Heg D, Juni P, Windecker S. Impact of Diabetic Status on Outcomes After Revascularization With Drug-Eluting Stents in Relation to Coronary Artery Disease Complexity: Patient-Level Pooled Analysis of 6081 Patients Circ Cardiovasc Interv. 2016;9:e003255 your personal reprint

February 2016: [National Guidelines for Medical Care of Patients with (Suspected) Coronary Artery Disease in Germany] Nationale Versorgungsleitlinien (NVL) “Chronische KHK”: Aktualisierung des Kapitels “Diagnostik bei (V.a.) KHK” (all in German language) [Full version] Gesamtfassung der NVL “Chronische KHK” [Guideline Report] Leitlinienreport Web Site of National Guidelines for Patient Care in Germany Web Site der Nationalen Versorgungsleitlinien

Silber S., Witzenbichler B, Vester E. [Optimal Oral Platelet Inhibition in Patients after Acute Coronary Syndrome (ACS): When to begin ? which drug ? how long ?] Optimale orale Thrombozytenaggregationshemmung (TAH) bei Patienten mit und nach akutem Koronarsyndrom (ACS): Wann beginnen, womit und wie lange? Eine Therapieempfehlung des BIK - Berufsverband Interventioneller Kardiologen - e.V., Recommendation of the Society of Interventional Cardiologists in Germany Update 2015 (in German language) your personal reprint

Vranckx P, Kalesan B, Stefanini GG, Farooq V, Onuma Y, Silber S, de Vries T, Juni P, Serruys PW, Windecker S. Clinical outcome of patients with stable ischaemic heart disease as compared to those with acute coronary syndromes after percutaneous coronary intervention. EuroIntervention, 2015;11:171-179 your personal reprint

Kelbaek H, Holmvang L, Richardt G, Eberli FR, Stella P, Buszman PE, Neumann FJ, Serruys PW, Windecker S, Widimsky P, Belardi JA, Silber S. Clinical results with the Resolute zotarolimus-eluting stent in total coronary occlusions. EuroIntervention. 2015;11:650-657 your personal reprint

Chevalier B, Wijns W, Silber S, Garcia E, Serra A, Paunovic D, Serruys P, investigators N. Five-year clinical outcome of the Nobori drug-eluting coronary stent system in the treatment of patients with coronary artery disease: final results of the NOBORI 1 trial. EuroIntervention. 2015;11:549-554 your personal reprint

Dudek D, Dziewierz A, Brener SJ, Abizaid A, Merkely B, Costa RA, Bar E, Rakowski T, Kornowski R, Dressler O, Abizaid A, Silber S, Stone GW. Mesh-covered embolic protection stent implantation in ST-segment-elevation myocardial infarction: final 1-year clinical and angiographic results from the MGUARD for acute ST elevation reperfusion trial. Circ Cardiovasc Interv. 2015;8:e001484 your personal reprint

Diletti R, Garcia-Garcia HM, Bourantas C, Van Mieghem NM, van Geuns RJ, Muramatsu T, Zhang YJ, Mauri L, Belardi J, Silber S, Widimsky P, Leon M, Windecker S, Meredith I, Neumann FJ, Yeung AC, Saito S, Liu M, van Leeuwen F, Serruys PW. Impact of body mass index on long-term clinical outcomes after second-generation drug eluting stent implantation: Insights from the international global RESOLUTE program. Catheter Cardiovasc Interv. 2015;85:952-958 your personal reprint

Piccolo R, Pilgrim T, Heg D, Franzone A, Rat-Wirtzler J, Raber L, Silber S, Serruys PW, Juni P, Windecker S. Comparative Effectiveness and Safety of New-Generation Versus Early-Generation Drug-Eluting Stents According to Complexity of Coronary Artery Disease: A Patient-Level Pooled Analysis of 6,081 Patients. JACC Cardiovasc Interv. 2015;8:1657-1666 your personal reprint

Costa RA, Abizaid A, Lotan C, Dudek D, Silber S, Dizon JM, Maehara A, Dressler O, Brener SJ, Stone GW. Impact of thrombus burden on outcomes after standard versus mesh-covered stents in acute myocardial infarction (from the MGuard for acute ST elevation reperfusion trial). Am J Cardiol. 2015;115:161-166 your personal reprint

Silber S. [Comparison of Stents in Coronary Artery Disease: Completely Absorbable Stents have no Proven Advantage] Stentvergleich bei KHK: Vollständig absorbierbare Stents bringen keinen gesicherten Vorteil Dtsch Med Wochenschr. 2015;140:386 (in German language)  your personal reprint

Iqbal J, Serruys PW, Silber S, Kelbaek H, Richardt G, Morel MA, Negoita M, Buszman PE, Windecker S. Comparison of zotarolimus- and everolimus-eluting coronary stents: final 5-year report of the RESOLUTE all-comers trial Circ Cardiovasc Interv. 2015;8:e002230 your personal reprint

Bourantas CV, Zhang YJ, Garg S, Iqbal J, Valgimigli M, Windecker S, Mohr FW, Silber S, Vries T, Onuma Y, Garcia-Garcia HM, Morel MA, Serruys PW. Prognostic implications of coronary calcification in patients with obstructive coronary artery disease treated by percutaneous coronary intervention: a patient-level pooled analysis of 7 contemporary stent trials. Heart, 2014;100:1158-1164 your personal reprint 

Vester EG, Bocksch W, Dörr R, Grebe O, Hoffmann S, Leitsch T, Silber S. [Oral Anticoagulation für Interventional Procedures in Cardiology Recommendation of the Society of Interventional Cardiology in Germany] Orale Antikoagulation bei interventionellen Eingriffen in der Kardiologie, Eine Therapieempfehlung des BIK - Berufsverband Interventioneller Kardiologen - e.V., Summer 2014  (in German language)  your personal reprint 

Kotzerke J, Silber S. Endovascular Brachytherapy to Prevent Restenosis After Percutaneous Coronary Intervention Book Chapter in: Therapeutic Nuclear Medicine, Editor: Richard P. Baum, Springer-Verlag Berlin Heidelberg 2014, ISSN 0942-5373  your personal reprint 

Witt S, Leidl R, Becker C, Holle R, Block M, Brachmann J, Silber S, Stollenwerk B. The effectiveness of the cardiovascular disease prevention programme ‘KardioPro’ initiated by a German sickness fund: a time-to-event analysis of routine data. PLoS One. 2014;9:e114720  your personal reprint 

Leistner DM, Klotsche J, Palm S, Pieper L, Stalla GK, Lehnert H, Silber S, März W, Wittchen HU, Zeiher AM for the DETECT study group. Prognostic value of reported chest pain for cardiovascular risk stratification in primary care. European Journal of Preventive Cardiology. 2014;21:727-738 your personal reprint 

Loh JP, Stella PR, Sangiorgi G, Silber S, Stahnke S, von Strandmann RP, Torguson R, Waksman R. Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: subanalysis results from the Valentines I trial. Cardiovascular Revascularization Medicine, 2014;15:23-28 your personal reprint 

Schäfer A, Arntz HR, Boudriot E, Garlichs C, Hoffmann S, Ince H, Klingenheben T, Weil J, Zugck C, Helms TM, Silber S. [Differentiated antiplatelet therapy for acute coronary syndromes] Differenzierte antithrombozytäre Therapie bei akutem Koronarsyndrom Dtsch Med Wochenschr, 1390: 152–158 (2014) (in German language)  your personal reprint

Kolh P, Windecker S, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Juni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A, European Society of Cardiology Committee for Practice G, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Committee ECG, Sousa Uva M, Achenbach S, Pepper J, Anyanwu A, Badimon L, Bauersachs J, Baumbach A, Beygui F, Bonaros N, De Carlo M, Deaton C, Dobrev D, Dunning J, Eeckhout E, Gielen S, Hasdai D, Kirchhof P, Luckraz H, Mahrholdt H, Montalescot G, Paparella D, Rastan AJ, Sanmartin M, Sergeant P, Silber S, Tamargo J, ten Berg J, Thiele H, van Geuns RJ, Wagner HO, Wassmann S, Wendler O, Zamorano JL, Task Force on Myocardial Revascularization of the European Society of C, the European Association for Cardio-Thoracic S, European Association of Percutaneous Cardiovascular I. 2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg. 2014;46:517-592 your personal reprint

Aljutaili M, Becker C, Witt S, Holle R, Leidl R, Block M, Brachmann J, Silber S, Bestehorn K, Stollenwerk B. Should health insurers target prevention of cardiovascular disease? A cost-effectiveness analysis of an individualised programme in Germany based on routine data. BMC Health Serv Res. 2014;14:263 your personal reprint 

Taniwaki M, Stefanini GG, Silber S, Richardt G, Vranckx P, Serruys PW, Buszman PE, Kelbaek H, Windecker S. 4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention). J Am Coll Cardiol. 2014;63:1617-1625 your personal reprint 

Stefanini GG, Taniwaki M, Kalesan B, Raber L, Stortecky S, Pilgrim T, Onuma Y, Silber S, Serruys PW, Meier B, Juni P, Windecker S. The impact of renal impairment on long-term safety and effectiveness of drug-eluting stents. PLoS One. 2014;9:e106450 your personal reprint 

Ferenc M, Kornowski R, Belardi J, Serruys P, Silber S, Widimsky P, Windecker S, Neumann FJ. Three-year outcomes of percutaneous coronary intervention with next-generation zotarolimus-eluting stents for de novo coronary bifurcation lesions. J Invasive Cardiol. 2014;26:630-638 your personal reprint

Caputo R, Leon M, Serruys P, Neumann FJ, Yeung A, Windecker S, Belardi JA, Silber S, Meredith I, Widimsky P, Saito S, Mauri L. Performance of the resolute zotarolimus-eluting stent in small vessels. Catheter Cardiovasc Interv. 2014;84:17-23 your personal reprint 

Dudek D, Brener SJ, Rakowski T, Dziewierz A, Abizaid A, Silber S, Yaacoby E, Dizon JM, Costa RA, Maehara A, Dressler O, Stone GW. Efficacy of an Embolic Protection Stent as a Function of Delay to Reperfusion in ST-Segment Elevation Myocardial Infarction (from the MASTER Trial). Am J Cardiol. 2014;114:1485-1489 your personal reprint 

Silber S, Kirtane AJ, Belardi JA, Liu M, Brar S, Rothman M, Windecker S. Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation.  Eur Heart J. 2014;35:1949-1956 your personal reprint

2014: [National Guidelines for Medical Care of Patients with Chronic Coronary Artery Disease in Germany] Nationale Versorgungsleitlinien (NVL) “Chronische KHK”: Aktualisierung des Kapitels “Revaskularisationstherapie” (all in German language)  [Full version] Gesamtfassung der NVL “Chronische KHK” [Guideline Report] Leitlinienreport Web Site of National Guidelines for Patient Care in Germany Web Site der Nationalen Versorgungsleitlinien

Widimsky P, Motovska Z, Belardi J, Serruys P, Silber S, Windecker S, Neumann FJ. Long-term outcomes of patients receiving zotarolimus-eluting stents in ST elevation myocardial infarction, non-ST elevation acute coronary syndrome, and stable angina: data from the Resolute program. Int J Cardiol. 2013;168:3522-3526   your personal reprint 

Willich SN, Müller-Riemenschneider F, McBride D, Silber S, Kuck KH, Nienaber CA, Schneider S, Senges J, Brüggenjürgen B. Health economic evaluation of the use of drug-eluting stents : First results from the Drug-Eluting Stent Registry (DES.de). Herz, 2013; 38:57-64   your personal reprint 

Vranckx P, McFadden E, Cutlip DE, Mehran R, Swart M, Kint PP, Zijlstra F, Silber S, Windecker S, Serruys PW. Clinical endpoint adjudication in a contemporary all-comers coronary stent investigation: methodology and external validation. Contemporary Clinical Trials. 2013;34:53-59   your personal reprint 

Silber S, Serruys PW, Leon MB, Meredith IT, Windecker S, Neumann FJ, Belardi J, Widimsky P, Massaro J, Novack V, Yeung AC, Saito S, Mauri L. Clinical outcome of patients with and without diabetes mellitus after percutaneous coronary intervention with the resolute zotarolimus-eluting stent: 2-year results from the prospectively pooled analysis of the international global RESOLUTE program. JACC Cardiovasc Interv. 2013;6:366-377   your personal reprint 

Richardt G, Leschke M, Abdel-Wahab M, Toelg R, El-Mawardy M, Serruys PW, Silber S, Windecker S, Belardi JA, Neumann FJ, Widimsky P.  Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis. JACC Cardiovasc Interv. 2013;6:905-913   your personal reprint 

Leistner DM, Klotsche J, Pieper L, Palm S, Stalla GK, Lehnert H, Silber S, März W, Wittchen HU, Zeiher AM. Prognostic value of NT-pro-BNP and hs-CRP for risk stratification in primary care: results from the population-based DETECT study. Clin Res Cardiol. 2013;102:259-268   your personal reprint 

Haude M, Lee SW, Worthley SG, Silber S, Verheye S, Erbs S, Rosli MA, Botelho R, Meredith I, Sim KH, Stella PR, Tan HC, Whitbourn R, Thambar S, Abizaid A, Koh TH, Den Heijer P, Parise H, Cristea E, Maehara A, Mehran R. The REMEDEE trial: a randomized comparison of a combination sirolimus-eluting endothelial progenitor cell capture stent with a paclitaxel-eluting stent. JACC Cardiovasc Interv. 2013;6:334-343   your personal reprint 

Farooq V, Vranckx P, Mauri L, Cutlip DE, Belardi J, Silber S, Widimsky P, Leon M, Windecker S, Meredith I, Negoita M, van Leeuwen F, Neumann FJ, Yeung AC, Garcia-Garcia HM, Serruys PW. Impact of overlapping newer generation drug-eluting stents on clinical and angiographic outcomes: pooled analysis of five trials from the international Global RESOLUTE Program. Heart. 2013;99:626-633   your personal reprint 

Costa JR, Jr., Abizaid A, Dudek D, Silber S, Leon MB, Stone GW. Rationale and design of the MGuard for acute ST elevation reperfusion MASTER trial. Catheter Cardiovasc Interv. 2013;82:184-190   your personal reprint 

Bramlage P, Cuneo A, Zeymer U, Hochadel M, Richardt G, Silber S, Senges J, Nienaber CA, Tebbe U, Kuck KH. Prognosis of patients with atrial fibrillation undergoing percutaneous coronary intervention receiving drug eluting stents. Clin Res Cardiol. 2013;102:289-297  your personal reprint 

Diletti R, Garcia-Garcia HM, Bourantas CV, van Geuns RJ, Van Mieghem NM, Vranckx P, Zhang YJ, Farooq V, Iqbal J, Wykrzykowska JJ, de Vries T, Swart M, Teunissen Y, Negoita M, van Leeuwen F, Silber S, Windecker S, Serruys PW Clinical outcomes after zotarolimus and everolimus drug eluting stent implantation in coronary artery bifurcation lesions: insights from the RESOLUTE All Comers Trial. Heart, 2013;99:1267-1274 your personal reprint 

Silber S, Basler M, Gerhard N: Possibilities and obstacles of the German Reimbursement System (G-DRG) for the implementation of guideline-recommended adjunctive technical devices for percutaneous coronary interventions Confluence, Issue 6, 12 - 15, (2012)   your personal reprint 

Silber S. The RESOLUTE clinical programme: one month DAPT data presented at TCT Confluence, Issue 6, 31 - 33, (2012)   your personal reprint 

Labeit AM, Klotsche J, Pieper L, Pittrow D, Einsle F, Stalla GK, Lehnert H, Silber S, Zeiher AM, Marz W, Wehling M, Wittchen HU. Changes in the prevalence, treatment and control of hypertension in Germany? A clinical-epidemiological study of 50.000 primary care patients. PLoS One. 2012;7:e52229   your personal reprint 

Vranckx P, Farooq V, Garg S, Van Es GA, Silber S, Windecker S, Stone GW, Serruys PW. Different cardiac biomarkers to detect peri-procedural myocardial infarction in contemporary coronary stent trials: impact on outcome reporting. Heart. 2012;98:1424-1430   your personal reprint 

Stone GW, Abizaid A, Silber S, Dizon JM, Merkely B, Costa RA, Kornowski R, Abizaid A, Wojdyla R, Maehara A, Dressler O, Brener SJ, Bar E, Dudek D: Prospective, Randomized, Multicenter Evaluation of a Polyethylene Terephthalate Micronet Mesh-Covered Stent (MGuard) in ST-Segment Elevation Myocardial Infarction: The MASTER Trial. J Am Coll Cardiol, 60:1975–1984 (2012)   your personal reprint 

Stefanini GG, Kalesan B, Pilgrim T, Raber L, Onuma Y, Silber S, Serruys PW, Meier B, Juni P, Windecker S. Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents. JACC Cardiovasc Interv; 5:301-310 (2012)  your personal reprint 

Van de Werf F, Ardissino D, Bueno H, Collet JP, Gershlick A, Kolh P, Kristensen SD, Silber S, Verheugt F, Wojakowski W. Acute coronary syndromes: Considerations for improved acceptance and implementation of management guidelines. Expert Rev Cardiovasc Ther; 10:489-503 (2012)   your personal reprint 

Neumann FJ, Cremer J, Falk V, Reifart N, Silber S, Thielmann M.[Comments on the joint guidelines on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)]  Kommentar zu den gemeinsamen „Guidelines on Myocardial Revascularization“ der European Society of Cardiology (ESC) und der European Association for Cardio-Thoracic Surgery (EACTS) Der Kardiologe; 6: 94 – 104 (2012)   (in German language)  your personal reprint  Pocket Guidelines Myocardial Revascularization 

Abdel-Wahab M, Nienaber CA, Mostafa AE, Ferenc M, Silber S, Sabin G, Tebbe U, Akin I, Hochadel M, Senges J, Kuck KH, Richardt G. Treatment of coronary bifurcation lesions with drug-eluting stents: Insights from the first phase of the prospective multicenter german drug-eluting stent registry. J Interv Cardiol. 2012;25:344-352   your personal reprint 

Beijk MA, Damman P, Klomp M, Woudstra P, Silber S, Grisold M, Ribeiro EE, Suryapranata H, Wojcik J, Sim KH, Tijssen JG, de Winter AR. Twelve-month clinical outcomes after coronary stenting with the genous bio-engineered R stent in patients with a bifurcation lesion: From the e-HEALING (healthy endothelial accelerated lining inhibits neointimal growth) registry. Coronary Artery Disease; 23:201-207 (2012)   your personal reprint 

Damman P, Klomp M, Silber S, Beijk MA, Ribeiro EE, Suryapranata H, Wojcik J, Sim KH, Tijssen JG, de Winter RJ. Duration of dual antiplatelet therapy and outcomes after coronary stenting with the genous bio-engineered R stent in patients from the e-HEALING registry. Catheter Cardiovasc Interv; 79:243-252 (2012)   your personal reprint 

Klomp M, Damman P, Beijk MA, Silber S, Grisold M, Ribeiro EE, Suryapranata H, Wojcik J, Sim KH, Tijssen JG, de Winter RJ. Applying the national institute for clinical excellence criteria to patients treated with the genous bio-engineered R stent: A sub-study of the e-HEALING (healthy endothelial accelerated lining inhibits neointimal growth) worldwide registry. Heart Vessels; 27:360-369 (2012)   your personal reprint 

Leistner DM, Klotsche J, Palm S, Pieper L, Stalla GK, Lehnert H, Silber S, März W, Wittchen HU, Zeiher AM. Resting heart rate as a tool for risk stratification in primary care: Does it provide incremental prognostic information? European Journal of Preventive Cardiology; 19:275-284 (2012) your personal reprint 

Leistner DM, Klotsche J, Pieper L, Stalla GK, Lehnert H, Silber S, März W, Wittchen HU, Zeiher AM. Circulating troponin as measured by a sensitive assay for cardiovascular risk assessment in primary prevention. Clin Chem; 58:200-208 (2012)   your personal reprint 

Klomp M, Damman P, Beijk MA, Tan KH, Balian V, de Luca G, Tijssen JG, Silber S, de Winter RJ. Differences in cardiovascular risk factors and clinical outcomes between western european and southeast asian patients treated with the genous bio-engineered R stent: An e-HEALING worldwide registry substudy. Coronary Artery Disease; 23:271-277 (2012)   your personal reprint 

Silber S, Tan HC, Iniguez A, Scacciatella P, Smith D, Kutryk M, Brugaletta S  Relative clinical contraindications to the use of drug-eluting stents: what are the alternatives? Cardiology International, 45 - 48 (2012)   your personal reprint 

Schneider HJ, Klotsche J, Friedrich N, Schipf S, Volzke H, Silber S, Marz W, Nauck M, Pittrow D, Wehling M, Sievers C, Lehnert H, Stalla GK, Wittchen HU, Wallaschofski H. Risk factors associated with the metabolic syndrome in abdominal obesity. Clin Obes. 2012;2:142-149   your personal reprint 

Silber S, Helms T, Berger H-J, Braun P, Hoffmann S, Schäfer A, Vester E. [Optimal Platelet Inhibition in Patients with Acute Coronary Syndrome (ACS)] Optimale Thrombozytenaggregationshemmung bei Patienten mit akutem Koronarsyndrom (ACS). Recommendations of the Society of Inverventional Cardiology in Germany 1st Version, Spring 2012 (in German language)  your personal reprint 

Silber S, Schuhbeck A: [The Right Nutrition for Heart and Circulation] Book Chapter in: A. Schuhbeck: Die Heilkraft von Omega-3, Seiten 24 - 27 Verlag Zabert Sandmann GmbH, München, 1. Auflage 2011, ISBN 978-3-89883-273-1 (in German language)  your personal reprint 

[National Guidelines for Patient Care in Germany regarding Chronic Coronary Artery Disease] Nationale Versorgungsleitlinien der Bundesärztekammer, Kassenärztlichen Bundesvereinigung und der Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften zur chronischen koronaren Herzkrankheit 2011 (in German language)  www.versorgungsleitlinien.de

Bauer T, Möllmann H, Weidinger F, Zeymer U, Seabra-Gomes R, Eberli F, Serruys P, Vahanian A, Silber S, Wijns W, Hochadel M, Nef HM, Hamm CW, Marco J, Gitt AK Impact of diabetes mellitus status on coronary pathoanatomy and interventional treatment: Insights from the EURO HEART survey PCI registry. Catheter Cardiovasc Interv; 78:702-709 (2011)   your personal reprint 

Bauer T, Nienaber CA, Akin I, Kuck KH, Hochadel M, Senges J, Fetsch T, Tebbe U, Willich SN, Stumpf J, Sabin GV, Silber S, Richardt G, Zahn R. Comparison between on-label versus off-label use of drug-eluting coronary stents in clinical practice: Results from the German DES.DE-Registry. Clin Res Cardiol; 100:701-709 (2011) your personal reprint

Damman P, Iniguez A, Klomp M, Beijk M, Woudstra P, Silber S, Ribeiro EE, Suryapranata H, Sim KH, Tijssen JG, de Winter RJ. Coronary stenting with the genous bio-engineered R stent in elderly patients. Circ J; 75:2590-2597 (2011) your personal reprint

Damman P, Klomp M, Beijk MA, Silber S, Grisold M, Ribeiro EE, Suryapranata H, Wojcik J, Sim KH, Tijssen JG, de Winter RJ.  Twelve-month outcomes after coronary stenting with the genous bio-engineered R stent in diabetic patients from the e-HEALING registry. J Interv Cardiol; 24:285-294 (2011) your personal reprint 

De Mulder M, Gitt A, van Domburg R, Hochadel M, Seabra-Gomes R, Serruys PW, Silber S, Weidinger F, Wijns W, Zeymer U, Hamm C, Boersma E. Euroheart score for the evaluation of in-hospital mortality in patients undergoing percutaneous coronary intervention. Eur Heart J; 32:1398-1408 (2011) your personal reprint 

den Dekker WK, Houtgraaf JH, Onuma Y, Benit E, de Winter RJ, Wijns W, Grisold M, Verheye S, Silber S, Teiger E, Rowland SM, Ligtenberg E, Hill J, Wiemer M, den Heijer P, Rensing BJ, Channon KM, Serruys PW, Duckers HJ. Final results of the HEALING-IIb trial to evaluate a bio-engineered cd34 antibody coated stent (Genous stent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients. Atherosclerosis; 219:245-252 (2011) your personal reprint

Garg S, Serruys PW, Silber S, Wykrzykowska J, van Geuns RJ, Richardt G, Buszman PE, Kelbaek H, van Boven AJ, Hofma SH, Linke A, Klauss V, Wijns W, Macaya C, Garot P, DiMario C, Manoharan G, Kornowski R, Ischinger T, Bartorelli A, Van Remortel E, Ronden J, Windecker S. The prognostic utility of the syntax score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: A substudy of the resolute all comers trial. JACC Cardiovasc Interv; 4:432-441 (2011)   your personal reprint 

Gomez-Lara J, Heo JH, Brugaletta S, Garg S, Garcia-Garcia HM, van Geuns RJ, Silber S, Windecker S, Serruys PW. Risk of target lesion failure in relationship to vessel angiographic geometry and stent conformability using the second generation of drug-eluting stents. Am Heart J; 162:1069-1079 e1062 (2011) your personal reprint

Gutierrez-Chico JL, van Geuns RJ, Regar E, van der Giessen WJ, Kelbaek H, Saunamaki K, Escaned J, Gonzalo N, di Mario C, Borgia F, Nuesch E, Garcia-Garcia HM, Silber S, Windecker S, Serruys PW. Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. A fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: An optical coherence tomography substudy from the resolute all comers trial. Eur Heart J; 32:2454-2463 (2011) your personal reprint

Schneider HJ, Klotsche J, Silber S, Stalla GK, Wittchen HU. Measuring abdominal obesity: Effects of height on distribution of cardiometabolic risk factors risk using waist circumference and waist-to-height ratio. Diabetes Care; 34:e7 (2011) your personal reprint

Silber S, Damman P, Klomp M, Beijk MA, Grisold M, Ribeiro EE, Suryapranata H, Wojcik J, Hian Sim K, Tijssen JG, de Winter RJ. Clinical results after coronary stenting with the genous bio-engineered R stent: 12-month outcomes of the e-HEALING (healthy endothelial accelerated lining inhibits neointimal growth) worldwide registry. EuroIntervention; 6:819-825 (2011) your personal reprint

Silber S, Gutierrez-Chico JL, Behrens S, Witzenbichler B, Wiemer M, Hoffmann S, Slagboom T, Harald D, Suryapranata H, Nienaber C, Chevalier B, Serruys PW. Effect of paclitaxel elution from reservoirs with bioabsorbable polymer compared to a bare metal stent for the elective percutaneous treatment of de novo coronary stenosis: The EUROSTAR-II randomised clinical trial. EuroIntervention; 7:64-73 (2011) your personal reprint

Silber S, Helms TM, Garlichs C, Arntz HR, Weil J, Ince H, Klingenheben T, Hoffmann S, Boudriot E, Steiger H, Zugck C. [Prasugrel for acute and long-term treatment of patients with acute coronary syndromes: what is state-of-the-art?]  Prasugrel in der Akut- und Nachbehandlung des akuten Koronarsyndroms: Wie ist der aktuelle Stand? Dtsch Med Wochenschr; 136:782-785 (2011)   (in German language)  your personal reprint 

Silber S, Windecker S, Vranckx P, Serruys PW.  Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the resolute all comers trial Lancet; 377:1241-1247 (2011)   your personal reprint 

Stefanini GG, Serruys PW, Silber S, Khattab AA, van Geuns RJ, Richardt G, Buszman PE, Kelbaek H, van Boven AJ, Hofma SH, Linke A, Klauss V, Wijns W, Macaya C, Garot P, Di Mario C, Manoharan G, Kornowski R, Ischinger T, Bartorelli AL, Gobbens P, Windecker S. The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: A substudy of the resolute all comers trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary intervention). J Am Coll Cardiol; 57:2221-2232 (2011) your personal reprint

Stella PR, Belkacemi A, Waksman R, Stahnke S, Torguson R, von Strandmann RP, Agostoni P, Sangiorgi G, Silber S.  The VALENTINES trial: Results of the first one week worldwide multicentre enrolment trial, evaluating the real world usage of the second generation dior paclitaxel drug-eluting balloon for in-stent restenosis treatment. EuroIntervention; 7:705-710 (2011) your personal reprint

Bauer T, Möllmann H, Weidinger F, Zeymer U, Seabra-Gomes R, Eberli F, Serruys P, Vahanian A, Silber S, Wijns W, Hochadel M, Nef HM, Hamm CW, Marco J, Gitt AK. Predictors of hospital mortality in the elderly undergoing percutaneous coronary intervention for acute coronary syndromes and stable angina. Int J Cardiol; 151:164-169 (2011) your personal reprint 

Silber S. Immediate and Long-Term Therapy of Patients with Acute Coronary Syndromes with Thienopyridines. Current Status According to the Latest European Society of Cardiology (ESC) Guidelines RMMJ; 2: e0056 (2011)   your personal reprint 

Silber S,Van de Werf F. and Members of the Task Force ESC/DGK Pocket-Leitlinie: Akutes Koronarsyndrom mit persistierender ST- Streckenhebung (STEMI)  Der Kardiologe; 4:93-106 (2010) your personal reprint 

Silber S, Borggrefe M, Hasenfuß G, Falk V, Kastrati A, Weis M, Hamm CW. [Commentary on the guidelines of the European Society of Cardiology (ESC) regarding the diagnosis and treatment of patients with ST-segment elevation myocardial infarction (STEMI)]  Kommentare zu den Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) zur Diagnostik und Therapie von Patienten mit ST-Streckenhebungsinfarkt (STEMI) Der Kardiologe; 4:84-92 (2010) (in German language)  your personal reprint 

Bauer T, Möllmann H, Weidinger F, Zeymer U, Seabra-Gomes R, Eberli F, Serruys P, Vahanian A, Silber S, Wijns W, Hochadel M, Nef HM, Hamm CW, Marco J, Gitt AK. Use of platelet glycoprotein IIb/IIIa inhibitors in diabetics undergoing PCI for non-ST-segment elevation acute coronary syndromes: Impact of clinical status and procedural characteristics. Clin Res Cardiol; 99:375-383 (2010) your personal reprint

Mahabadi AA, Achenbach S, Burgstahler C, Dill T, Fischbach R, Knez A, Moshage W, Richartz BM, Ropers D, Schröder S, Silber S, Möhlenkamp S. Safety, efficacy, and indications of beta-adrenergic receptor blockade to reduce heart rate prior to coronary ct angiography. Radiology; 257:614-623 (2010) your personal reprint

Schneider HJ, Friedrich N, Klotsche J, Pieper L, Nauck M, John U, Dorr M, Felix S, Lehnert H, Pittrow D, Silber S, Volzke H, Stalla GK, Wallaschofski H, Wittchen HU. The predictive value of different measures of obesity for incident cardiovascular events and mortality. J Clin Endocrinol Metab; 95:1777-1785 (2010) your personal reprint

Serruys PW, Silber S, Garg S, van Geuns RJ, Richardt G, Buszman PE, Kelbaek H, van Boven AJ, Hofma SH, Linke A, Klauss V, Wijns W, Macaya C, Garot P, DiMario C, Manoharan G, Kornowski R, Ischinger T, Bartorelli A, Ronden J, Bressers M, Gobbens P, Negoita M, van Leeuwen F, Windecker S. Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. N Engl J Med; 363:136-146 (2010)  your personal reprint Originalarbeit your personal reprint Appendix

Silber S.  [Evidence-based management of ST-segment elevation myocardial infarction (STEMI). Latest guidelines of the European Society of Cardiology (ESC) 2010 ] Evidenzbasiertes Vorgehen beim ST-Strecken- Hebungsinfarkt (STEMI): Neueste Leitlinien der Europäischen Gesellschaft für Kardiologie (ESC) 2010 Herz; 35:558-564 (2010) (in German language)  your personal reprint

Vranckx P, Cutlip DE, Mehran R, Kint PP, Silber S, Windecker S, Serruys PW. Myocardial infarction adjudication in contemporary all-comer stent trials: Balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies. EuroIntervention; 5:871-874 (2010) your personal reprint

Hoffmeister HH, Bode C, Darius H, Huber K, Rybak K, Silber S. [Bridging of Antithrombotic Therapy in Patients with Cardiovascular Disease. Position paper of the German Society of Cardiology ] Unterbrechung antithrombotischer Behandlung (Bridging) bei kardialen Erkrankungen Positionspapier der Deutschen Gesellschaft für Kardiologie (DGK) Der Kardiologe; 4: 365-374 (2010) (in German language)  your personal reprint

Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T, Garg S, Huber K, James S, Knuuti J, Lopez-Sendon J, Marco J, Menicanti L, Ostojic M, Piepoli MF, Pirlet C, Pomar JL, Reifart N, Ribichini FL, Schalij MJ, Sergeant P, Serruys PW, Silber S, Sousa Uva M, Taggart D. Guidelines on Myocardial Revascularization of the European Society of Cardiology (ESC) Eur Heart J; 31:2501-2555 (2010) your personal reprint Eur J Cardiothorac Surg. 2010;38 Suppl:S1-S52 your personal reprint

Borggrefe M, Böhm M, Brachmann J, Figulla H-R, Hasenfuß G, Hoffmeister HM, Osterspey A, Rybak K, Sechtem U, Silber S.
Pocket-Guidelines: 
Diagnosis and Therapy of Acute Pulmonary Embolism
edited by
The Board of the German Socieety of Cardiology (DGK)
2009
(in German language) 
your personal reprint 

Richartz BM, Silber S
[Modern Nitrate Therapy with Special Analysis of the COURAGE and MASS-II Trials]
Die „Moderne Nitrattherapie“ unter besonderer Berücksichtigung der COURAGE- und MASS-II-Studien
Book Chapter in:
"Pentaerithrityl-tetranitrat: Experimentelle Befunde und Optionen"
ISBN 978-3-7985-1884-1, Steinkopff-Verlag, 75-79, (2009)
(in German language) 
your personal reprint 

Magro M, Onuma Y, Silber S, Serruys PW.
Transferability of data between different drug-eluting stents
EuroIntervention; 5:527-531 (2009)
your personal reprint

Chevalier B, Silber S, Park SJ, Garcia E, Schuler G, Suryapranata H, Koolen J, Hauptmann KE, Wijns W, Morice MC, Carrie D, van Es GA, Nagai H, Detiege D, Paunovic D, Serruys PW.
Randomized comparison of the nobori biolimus A9-eluting coronary stent with the taxus liberte paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: The NOBORI-1 trial—phase 2.
Circ Cardiovasc Interv; 2:188-195 (2009)
your personal reprint

Nienaber CA, Akin I, Schneider S, Senges J, Fetsch T, Tebbe U, Willich SN, Stumpf J, Sabin GV, Silber S, Richardt G, Kuck KH.
Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter german DES.DE registry).
Am J Cardiol; 104:1362-1369 (2009)
your personal reprint

Schäfers M, Bengel F, Büll U, Burchert W, Kies P, Kluge R, Krause BJ, Lindner O, Nienaber C, Nowak B, Schäfer W, Schober O, Schwaiger M, Silber S, Stegger L, vom Dahl J, Zimmermann R.
[Position paper on nuclear cardiology by the German Cardiac Society. State of the art of clinical application ]
Positionspapier Nuklearkardiologie: Aktueller Stand der klinischen Anwendung Im Namen der Arbeitsgemeinschaft „Kardiovaskuläre Nuklearmedizin“ der Deutschen Gesellschaft für Nuklearmedizin (DGN) und der Arbeitsgruppe „Nuklearkardiologische Diagnostik“ der Deutschen Gesellschaft für Kardiologie, Herz- und Kreislaufforschung (DGK)
Nuklearmedizin; 48:71-78 (2009)
Der Kardiologe; 3:283-293 (2009)
(in German language) 
your personal reprint

Silber S, Colombo A, Banning AP, Hauptmann K, Drzewiecki J, Grube E, Dudek D, Baim DS.
Final 5-year results of the TAXUS-II trial: A randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions.
 Circulation; 120:1498-1504 (2009)
your personal reprint

Silber S und Herdeg C.
[Coronary Interventions in Patients with Diabetes Mellitus - Only with Drug-Eluting Stents?]
Koronarinterventionen bei Diabetikern nur noch mit Drug-eluting Stents?
CardioVasc, 3, 38-40, (2008)
(in German language) 
your personal reprint

Daemen J, Simoons ML, Wijns W, Bagust A, Bos G, Bowen JM, Braunwald E, Camenzind E, Chevalier B, Dimario C, Fajadet J, Gitt A, Guagliumi G, Hillege HL, James S, Juni P, Kastrati A, Kloth S, Kristensen SD, Krucoff M, Legrand V, Pfisterer M, Rothman M, Serruys PW, Silber S, Steg PG, Tariah I, Wallentin L, Windecker SW, Aimonetti A, Allocco D, Baczynska A, Bagust A, Berenger M, Bos G, Boam A, Bowen JM, Braunwald E, Calle JP, Camenzind E, Campo G, Carlier S, Chevalier B, Daemen J, de Schepper J, Di Bisceglie G, Dimario C, Dobbels H, Fajadet J, Farb A, Ghislain JC, Gitt A, Guagliumi G, Hellbardt S, Hillege HL, Ten Hoedt R, Isaia C, James S, de Jong P, Juni P, Kastrati A, Klasen E, Kloth S, Kristensen SD, Krucoff M, Legrand V, Lekehal M, Lenarz L, Ni Mhullain F, Nagai H, Patteet A, Paunovic D, Pfisterer M, Potgieter A, Purdy I, Raveau-Landon C, Rothman M, Serruys PW, Silber S, Simoons ML, Steg PG, Tariah I, Ternstrom S, Van Wuytswinkel J, Waliszewski M, Wallentin L, Wijns W, Windecker SW.
ESC Forum on Drug-eluting Stents, European Heart House, Nice, 27-28 September 2007.
Eur Heart J; 30:152-161 (2009)
your personal reprint
EuroIntervention; 4:427-436 (2008)
your personal reprint

Essential Messages from ESC Guidelines 2008: AMI - STEMI
with "special thanks to Prof. Dr. Sigmund Silber for his contribution"

Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, Filippatos G, Fox K, Huber K, Kastrati A, Rosengren A, Steg PG, Tubaro M, Verheugt F, Weidinger F, Weis M, 

ESC Committee for Practice Guidelines (CPG): Alec Vahanian, John Camm, Raffaele De Caterina, Veronica Dean, Kenneth Dickstein, Gerasimos Filippatos, Christian Funck-Brentano, Irene Hellemans, Steen Dalby Kristensen, Keith McGregor, Udo Sechtem, Sigmund Silber, Michal Tendera, Petr Widimsky, José Luis Zamorano,

Document Reviewers: Sigmund Silber (Review Coordinator), Frank V. Aguirre, Nawwar Al-Attar, Eduardo Alegria, Felicita Andreotti, Werner Benzer, Ole Breithardt, Nicholas Danchin, Carlo Di Mario, Dariusz Dudek, Dietrich Gulba, Sigrun Halvorsen, Philipp Kaufmann, Ran Kornowski, Gregory Y. H. Lip, and Frans Rutten 
European Society of Cardiology (ESC) Guidelines on Management of Acute Myocardial Infarction in Patients presenting with persistent ST-Segment Elevation
European Heart J; 29: 2909–2945 (2008)
your personal reprint

Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K,

ESC Committee for Practice Guidelines (CPG): Alec Vahanian, John Camm, Raffaele De Caterina, Veronica Dean, Kenneth Dickstein, Gerasimos Filippatos, Christian Funck-Brentano, Irene Hellemans, Steen Dalby Kristensen, Keith McGregor, Udo Sechtem, Sigmund Silber, Michal Tendera, Petr Widimsky, Jose Luis Zamorano,

European Society of Cardiology (ESC) Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
European Heart J; 29: 2388 – 2442 (2008)
your personal reprint

Torbicki A, Perrier A, Konstantinides S, Agnelli G, Galie N, Pruszczyk P, Bengel F, Brady AJ, Ferreira D, Janssens U, Klepetko W, Mayer E, Remy-Jardin M, Bassand JP 

ESC Committee for Practice Guidelines (CPG): Alec Vahanian, John Camm, Raffaele De Caterina, Veronica Dean, Kenneth Dickstein, Gerasimos Filippatos, Christian Funck-Brentano, Irene Hellemans, Steen Dalby Kristensen, Keith McGregor, Udo Sechtem, Sigmund Silber, Michal Tendera, Petr Widimsky, Jose Luis Zamorano 
European Society of Cardiology (ESC) Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism
European Heart J; 29: 2276–2315 (2008)
your personal reprint

Silber S, Jarre F, Pittrow D, Klotsche J, Pieper L, Zeiher AM, Wittchen HU.
[Cardiovascular Risk Assessment by Primary-Care Physicians in Germany and its lack of Agreement with the Established Risk Scores (DETECT)]
Kardiovaskuläre Risikoabschätzung in der Hausarztpraxis (DETECT) Wie gut stimmt die Hausarzteinschätzung mit den etablierten Risikoscores überein?
Med Klin; 103:638-645 (2008)
(in German language)
your personal reprint

Silber S, Hoffmeister HM, Bode C.
[Optimal Platelet Inhibition after Coronary Stent Implantation. Current Status]
Optimale Thrombozytenaggregationshemmung nach koronarer Stentimplantation - Aktueller Stand
Herz; 33:244-253 (2008)
(in German language) 
your personal reprint

Silber S, Herdeg C.
[Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials]
Drug-eluting Stents bei Patienten mit Diabetes mellitus: Eine kritische Analyse der aktuellen Datenlage aus randomisierten Studien
Herz; 33:196-205 (2008)
(in German language) 
your personal reprint

Silber S, Borggrefe M, Böhm M, Hoffmeister HM, Dietz R, Ertl G, Heusch G.
[Drug-eluting coronary stents and drug eluting balloon catheters: summary of the position papers of the DGK]
Medikamente freisetzende Koronarstents (DES) und Medikamente freisetzende Ballonkatheter (DEB): Aktualisierung des Positionspapiers der Deutschen Gesellschaft für Kardiologie (DGK)
Clin Res Cardiol; 97:548-563 (2008)
(in German language) 
your personal reprint

Silber S
[25 years of progress in cardiology--coronary heart disease: advances through self-experimentation and serendipity]
25 Jahre Fortschritte in der Kardiologie:
Koronare Herzkrankheit - Selbstversuche und Zufälle brachten den Fortschritt.
MMW Fortschr Med; 150:82-83 (2008)
(in German language) 
your personal reprint

Schneider HJ, Klotsche J, Saller B, Bohler S, Sievers C, Pittrow D, Ruf G, März W, Erwa W, Zeiher AM, Silber S, Lehnert H, Wittchen HU, Stalla GK.
Associations of age-dependent igf-i sds with cardiovascular diseases and risk conditions: Cross-sectional study in 6773 primary care patients.
European Journal of Endocrinology / European Federation of Endocrine Societies;
158:153-161 (2008)
your personal reprint

Richartz BM, Schneider HT, Silber S
[PETN: long acting nitrate with tolerance devoiding properties and innovative potential]
PETN: das toleranzfreie Langzeitnitrat mit Innovationspotenzial - Eine Übersicht
MMW Fortschr Med; 150 Suppl 1:43-47 (2008)
your personal reprint

Kornowski R, Fort S, Almagor Y, Silber S, Lewis BS.
Impact of vessel size, lesion length and diabetes mellitus on angiographic restenosis outcomes: Insights from the NIRTOP study
Acute Card Care; 10:104-110 (2008)
your personal reprint

Finsterer S, Weyerbrock S, Basler M, Mühling H, Silber S
[Chronic heart failure: how can the family doctor put current guidelines into practice?]
Behandlung der chronischen Herzinsuffizienz: Wie Sie die aktuellen Leitlinien in der Praxis umsetzen.
MMW Fortschr Med; 150:29-33 (2008)
(in German language) 
your personal reprint

Bischoff B, Silber S, Richartz BM, Pieper L, Klotsche J, Wittchen HU [Frequency of Prescriptions of Slow-Release Nitrates for Patients with Coronary Artery Disease in Germany] Häufigkeit der Verordnung von Langzeitnitraten bei Patienten mit koronarer Herzerkrankung in Deutschland Book Chapter in: Pentaerithrityltetranitrat: NO-Therapie: Lebensqualität und prognostische Perspektiven Steinkopff Verlag Darmstadt, ISBN-10 3-7985-1725-8 5. Kapitel, 47-51 (2007) (in German language)  your personal reprint​

Silber S, Mathes P New Concepts for Early Diagnosis of Coronary Artery Disease Book Chapter in: Cardiovascular Prevention and Rehabilitation Editors: Perk P, Mathes, P, Gohlke H et al. Springer-Verlag London, ISBN.10: 1-84628-462-7, (2007) your personal reprint

Böhm M, Laufs U, Hamm C, Andresen D, Becker HJ, Borggrefe M, Brachmann J,  Dietz R, Ertl G, Fleck E, M.G. Gottwik MG, de Haan F, Hoffmeister HM, Heusch G, Meinertz T,  Osterspey A, Silber S, Trappe HJ [Position Paper of the German Society of Cardiology on Statin Therapy] Positionspapier zur Statintherapie Positionspapier der Deutschen Gesellschaft für Kardiologie (DGK) Clin Res Cardiol Suppl. 2: 8–15 (2007) (in German language)  your personal reprint

Nagel E, Bauer W, Sechtem U, Schulz-Menger J, Silber S, Voigtländer T, Moshage W, Kramer HH, Ertl G, Fleck, E [Clinical Indications for Cardiovascular Magnetic Resonance (CMR)] Klinische Indikationen für die kardiovaskuläre Magnetresonanztomographie (CMR) Positionspapier der Deutschen Gesellschaft für Kardiologie (DGK) Position Paper of the German Society of Cardiology Clin Res Cardiol Suppl. 2: 77–96 (2007) (in German language)  your personal reprint

Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F, Fox KA, Hasdai D, Ohman EM, Wallentin L, Wijns W. ESC Committee for Practice Guidelines: Vahanian A, Camm AJ, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007;28:1598-1660 your personal reprint

Vardas PE, Auricchio A, Blanc JJ, Daubert JC, Drexler H, Ector H, Gasparini M, Linde C, Morgado FB, Oto A, Sutton R, Trusz-Gluza M, European Society of C, European Heart Rhythm A. ESC Committee for Practice Guidelines: Vahanian A, Camm AJ, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J. 2007;28:2256-2295 your personal reprint

Silber S [Direct and Indirect NO-mediated Stimulation of Endthelial Progenotor Cells (EPC): Accelerated Endothelialisation of Coronary Stents - a Physiological Concept] Direkte und indirekte NO-vermittelte Stimulation der Endothelialen Progenitor Zellen (EPC): Beschleunigte Endothelialisierung von Koronarstents, ein physiologisches Konzept Book Chapter in: Therapie kardialer Erkrankungen – Neues aus Forschung und Klinik. Erdmann E, Lehmann J, Lüderitz B (Herausgeber) Steinkopff Verlag Darmstadt, ISBN 978-3-7985-1785-1; Kapitel 9: 85-110 (2007) (in German language)  your personal reprint

Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, Bonow R, Van der Wall EE, Bassand JP, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson PA, Gurfinkel EP, Lopez-Sendon JL, Pais P, Mendis S, Zhu JR, Wallentin LC, Fernandez-Aviles F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio-Pulkki LM, ESC Committee for Practice Guidelines: Vahanian A, Camm AJ, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL Universal Definition of Myocardial Infarction European Heart J; 28: 2525-2538 (2007) your personal reprint Circulation; 116:2634-2653 (2007) your personal reprint

Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL, Other experts who contributed to parts of the guidelines: Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL European Guidelines on Cardiovascular Disease Prevention in Clinical Practice: Fourth Joint Task Force of the European Society of Cardiology and other societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J; 28: 2375-2414 (2007)  your personal reprint Eur J Cardiovasc Prev Rehabil; 14 Suppl 2:E1-40 (2007) your personal reprint

Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker Boudier HA, Zanchetti ESC Committee for Practice Guidelines (CPG): A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL European Society of Cardiology (ESC) Guidelines for the Management of Arterial Hypertension: developed with the European Society of Hypertension (esh) and of the European Society of Cardiology (ESC) Eur Heart J; 28:1462-1536 (2007) your personal reprint

Silber S, Borggrefe M, Böhm M, Hoffmeister HM, Dietz R, Ertl G, Heusch G. [Position Paper of the German Society of Cardiology (DGK) on the Efficacy and Safety of Drug-Eluting Stents: An Evidence-Based Analysis of 71 Randomized Studies in 28.984 Patients] Positionspapier der Deutscen Gesellschaft für Kardiologie (DGK) zur Wirksamkeit und Sicherheit von Medikamente freisetzenden Koronarstents (DES): Eine evidenzbasierte Analyse von 71 randomisierten Studien mit 28.984 Patienten Der Kardiologe; 1:84-111 (2007) (in German language)  your personal reprint

Gohlke H, Albus C, Bönner G, Darius H, Eckert S, Gerber A, Gohlke-Bärwolf C, Gysan D, Kübler W, Lauterbach KW, Mathes P, von Schacky C, Sauer G, Schuler G, Siegrist J, Silber S, Tschöpe D, Thiery J, Wirth A. [Risk-Adjusted Prevention of Heart and Circulation Diseases] Risikoadjustierte Prävention von Herz- und Kreislauferkrankungen Pocket-Leitlinien der Deutschen Gesellschaft für Kardiologie, DGK Pocket Guidelines of the German Society of Cardiology (2007) (in German language)  your personal reprint 

Silber S, Richartz BM, Goss F, Haerer W, Glowatzki M, Schmieder RE. [Care of hypertensive patients seen by cardiologists: results of the Snapshot Hypertension Registry] Der Patient mit arterieller Hypertonie in der kardiologischen Facharztpraxis: Ergebnisse des Snapshot-Hypertonie-Registers. Ein Projekt des Bundesverbandes Niedergelassener Kardiologen (BNK e.V.) Dtsch Med Wochenschr; 132:2430-2435 (2007) (in German language)  your personal reprint 

Silber S, Richartz BM [Evidence-based application of cardiac magnetic resonance and cardiac computed tomography for primary diagnosis of stable coronary artery disease with special attention to disease management programs and the German National Medical Care Guidelines] Evidenzbasierter Einsatz von Kardio-MR und Kardio-CT in der Primärdiagnostik der stabilen koronaren Herzkrankheit unter besonderer Berücksichtigung des Disease-Management-Programms (DMP) KHK und der Nationalen Versorgungsleitlinie. Herz; 32:139-158 (2007) (in German language)  your personal reprint 

Lüscher TF, Silber S [Drug-eluting stents: breakthrough or time bomb] Drug-eluting Stents: Durchbruch oder Zeitbombe? Herz; 32:265-267 (2007) (in German language)  your personal reprint 

Fort S, Kornowski R, Silber S, Lewis BS, Bilodeau L, Almagor Y, van Remortel E, Morice MC, Colombo A. “Fused-gold” vs. “Bare” stainless steel nirflex stents of the same geometric design in diseased native coronary arteries. Long-term results from the nir top study. EuroIntervention; 3:256-261 (2007) your personal reprint 

Duckers HJ, Soullie T, den Heijer P, Rensing B, de Winter RJ, Rau M, Mudra H, Silber S, Benit E, Verheye S, Wijns W, Serruys PW. Accelerated vascular repair following percutaneous coronary intervention by capture of endothelial progenitor cells promotes regression of neointimal growth at long term follow-up: Final results of the HEALING-II trial using an endothelial progenitor cell capturing stent (Gensous R-stent). EuroIntervention; 3:350-358 (2007) your personal reprint 

Duckers HJ, Silber S, de Winter R, den Heijer P, Rensing B, Rau M, Mudra H, Benit E, Verheye S, Wijns W, Serruys PW. Circulating endothelial progenitor cells predict angiographic and intravascular ultrasound outcome following percutaneous coronary interventions in the HEALING-II trial: Evaluation of an endothelial progenitor cell capturing stent. EuroIntervention; 3:67-75 (2007) your personal reprint 

Chevalier B, Serruys PW, Silber S, Garcia E, Suryapranata H, Hauptmann K, Wijns W, Schuler G, Fath-Ordoubadi F, Worthley S, Thuesen L, Meredith I, Bressers M, Nagai H, Paunovic D. Randomised comparison of nobori, biolimus a9-eluting coronary stent with a taxus, paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: The NOBORI-1 trial.  EuroIntervention; 2:426-434 (2007) your personal reprint 

Beiras-Fernandez A, Kur F, Kazmarek I, Eifert S, Oberhoffer M, Silber S, Reichart B, Vicol C. Aberrant origin of the left main coronary artery arising from the right coronary artery associated with coronary artery disease: A case report Heart Surg Forum;10:E173-174 (2007) your personal reprint 

Böhler S, Scharnagl H, Freisinger F, Stojakovic T, Glaesmer H, Klotsche J, Pieper L, Pittrow D, Kirch W, Schneider H, Stalla GK, Lehnert H, Zeiher AM, Silber S, Koch U, Ruf G, Marz W, Wittchen HU. Unmet needs in the diagnosis and treatment of dyslipidemia in the primary care setting in germany. From the DETECT Study. Atherosclerosis; 190:397-407 (2007) your personal reprint 

Böhm M, Laufs U, Hamm C, Andresen D, Becker HJ, Borggrefe M, Brachmann J, Dietz R, Ertl G, Fleck E, Gottwik MG, de Haan F, Hoffmeister HM, Heusch G, Meinertz T, Osterspey A, Silber S, Trappe HJ Statement of the Cardiology Authors Regarding the “Assessment of Statins with Emphasis on Atorvastatin” Stellungnahme einer Autorengruppe aus der Kardiologie zur: „Nutzenbewertung der Statine unter besonderer Berücksichtigung von Atorvastatin“ des Instituts für Qualität und Wirtschaftlichkeit im Gesundheitswesen Deutsches Ärzteblatt, 103, A2250-A2252 (2006) (in German language)  your personal reprint

Silber S, Böhm M, Gottwik M, Borggrefe M, Dietz R. Avoidance of Death and Life-Threatening Complications by Additional Prescription of Clopidogrel Vermeidung von Tod und lebensbedrohlichen Komplikationen durch zusätzliche Gabe von Clopidogrel Positionspapier der Deutschen Gesellschaft für Kardiologie zur koronaren Stentimplantation Position Paper of the German Society of Cardiology (DGK) Herz, 31, Nr. 1, (2006) (in German language)  your personal reprint

Silber S, Böhm M, Gottwik M, Borggrefe M, Dietz R. [Risk of Myocardial Infarction Following Coronary Stent Implantation without Adequate Clopidogrel Treatment] Akutes Herzinfarktrisiko bei mangelnder Clopidogrelgabe nach koronarer Stentimplantation  Deutsches Ärzteblatt; 103: A 2863–2868 (2006) (in German language)  your personal reprint Response letters: Leserbriefe und Antworten: Deutsches Ärzteblatt; 104: A 1245–1247 (2007) (in German language)  your personal reprint

Silber S [Heart catheter in angina pectoris: must we set stricter indications?] Stabile KHK-Patienten; Mehr Schaden als Nutzen vom Herzkatheter? Müssen wir die Indikation strenger stellen? MMW Fortschr Med; 148:12-13 (2006) (in German language)  your personal reprint

Silber S, Richartz BM, Brilmayer M.  [The European Society of Cardiology (ESC) guidelines for percutaneous coronary interventions (PCI). Three case reports] Die ESC-Leitlinien zur perkutanen Koronarintervention (PCI): Drei Fallbesipiele Herz; 31:836-846, 848 (2006) (in German language)  your personal reprint

Silber S, Hoffmeister HM, Drexler C, Schächinger V, Kuon E. [Working instructions in the cardiac catheter laboratory. According to paragraph 18 (2): Radiographic regulation for a radiography facility for the use of x-rays with humans as a model]. Arbeitsanweisung im HKL gem. § 18 Abs. (2) Röntgenverordnung für eine Röntgeneinrichtung zur Anwendung von Röntgenstrahlung am Menschen als Muster Clin Res Cardiol; 95 Suppl 4:72-75 (2006) (in German language)  your personal reprint

Silber S Capturing circulating endothelial progenitor cells: A new concept tested in the healing studies. Minerva Cardioangiol; 54:1-3 (2006) your personal reprint

Silber S A new and rapid scoring system to assess the scientific evidence from clinical trials. J Interv Cardiol;19:485-492 (2006) your personal reprint

Radke PW, Figulla HR, Drexler H, Klues HG, Mügge A, Silber S, Daniel W, Schmeisser A, Reifart N, Motz W, Büttner HJ, Fischer D, Ortlepp JR, Schaefers K, Hoffmann R, Hanrath P. A double-blind, randomized, placebo-controlled multicenter clinical trial to evaluate the effects of the angiotensin ii receptor blocker candesartan cilexetil on intimal hyperplasia after coronary stent implantation. Am Heart J;152:761 e761-766 (2006) for the AACHEN Trial Investigators your personal reprint

Pittrow D, Stalla GK, Zeiher AM, Silber S, März W, Pieper L, Klotsche J, Glaesmer H, Ruf G, Schneider HJ, Lehnert H, Böhler S, Koch U, Wittchen HU. [Prevalence, drug treatment and metabolic control of diabetes mellitus in primary care] Prävalenz, medikamentöse Behandlung und Einstellung des Diabetes mellitus in der Hausarztpraxis Med Klin; 101:635-644 (2006) (in German language)  your personal reprint

Bischoff B, Silber S, Richartz BM, Pieper L, Klotsche J, Wittchen HU Inadequate Medical Treatment of Patients with Coronary Artery Disease by Primary Care Physicians in Germany. Clin Res Cardiol; 95:405-412 (2006) your personal reprint

Silber S [Arguments in favor of Integrated Health Care as regular health care provision in cardiology] Argumente für die Integrierte Versorgung als Regelversorgung in der Kardiologie Clin Res Cardiol 95: Suppl 2, II/37–II/40 (2006) (frühere Zeitschrift für Kardiologie) (in German language)  your personal reprint

Silber S
[Pro and Con of Disease Management Programs (DMP) and the Special Role of PETN in the DMP for Patients with Coronary Artery Disease]
Pro und Contra von Disease-Management Programmen (DMP) und die besondere Rolle des PETN beim DMP-KHK
Book Chapter in: 
Pharmakologische und klinische Aspekte für Disease Management Programme der koronaren Herzkrankheit.
ISBN 3-7985-1559-X. Steinkopff Verlag, Darmstadt, (2005)
(in German language) 
your personal reprint

Bassand JP, Danchin N, Filippatos G, Gitt A, Hamm C, Silber S, Tubaro M, Weidinger F.
Implementation of reperfusion therapy in acute myocardial infarction.
A policy statement from the European Society of Cardiology
Eur Heart J. 26: 2733-2741 (2005)
your personal reprint

Silber S, Richartz BM
[Impact of both cardiac-CT and cardiac-MR on the assessment of coronary risk].
Stellenwert von Kardio-CT und Kardio-MR zur Bestimmung des koronaren Risikos
Zeitschrift für Kardiologie 94: Suppl. 4, IV/1 - IV/11 (2005)
(in German language) 
your personal reprint

Pieper L, Wittchen HU, Glaesmer H, Klotsche J, März W, Stalla G, Lehnert H, Zeiher AM, Silber S, Koch U, Böhler S, Pittrow D, Ruf G.
[Cardiovascular High-Risk Patients in Primary Care in Germany: DETECT Study 2003]
Kardiovaskuläre Hochrisikokonstellationen in der primarärztlichen Versorgung: DETECT-Studie 2003
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz.
48:1374-1382 (2005)
(in German language) 
your personal reprint

Silber S
Cypher versus Taxus: are there differences?
J Interv Cardiol. 18: 441-446 (2005)
your personal reprint

Grube E, Silber S, Hauptmann KE, Büllesfeld L, Müller R, Lim V, Gerckens U, Russell ME
Two-year-plus follow-up of a paclitaxel-eluting stent in de novo coronary narrowings (TAXUS I)
Am J Cardiol 96:79-82 (2005)
your personal reprint

Fricke HU, Silber S
[Can PCI with drug-eluting stents replace coronary artery bypass surgery? A comparative economic analysis regarding both therapeutic options based on clinical 12-month data reflecting the German social health care insurance system]
Können Medikamente freisetzende Koronarstents eine Bypassoperation ersetzen?
Herz 30:332-338 (2005)
(in German language) 
your personal reprint

Silber S, Popma JJ, Suntharalingam M, Lansky AJ, Heuser RR, Speiser B, Teirstein PS, Bass T, O"Neill W, Lasala J, Reisman M, Sharma SK, Kuntz RE, Bonan R
Two-year clinical follow-up of 90Sr/90Y beta-radiation versus placebo control for the treatment of in-stent restenosis (START)
Am Heart J. 149:689-694, (2005)
your personal reprint

Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, Jorgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W
Leitlinien für Koronarinterventionen (PCI):
Guidelines for Percutaneous Coronary Interventions (PCI): the Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology (ESC).
European Heart J. 26:804-847, (2005)
your personal reprint

Letters to the Editor and Reply:
European Heart J; 27:1757-1759, (2006)
your personal reprint

Wittchen HU, Glaesmer H, Silber S, März W, Stalla G, Lehnert H, Zeiher AM, , Koch U, Böhler S, Pittrow D, Ruf G
Cardiovascular risk factors in primary care: methods and baseline prevalence rates – the DETECT program.
Current Medical Research and Opinion, 21: 619–629, (2005)
your personal reprint

Silber S
Author Reply:
[Guideline conforming interventional therapy of acute ST elevation infarct in rural regions by network development--on the contribution in DMW 42/2004]. Dtsch Med Wochenschr. 2005;130:299]
Leserbrief zu:
"Leitlinienkonforme interventionelle Therapie des akuten ST-Hebungsinfarktes in ländlichen Regionen durch Netzwerkbildung" (zum Beitrag aus DMW 41/2004)
Dtsch Med Wochenschr. 130:299, (2005)
(in German language) 
your personal reprint

Silber S
[Typically German ?]
Reader's Letter
Typisch deutsch ?
Leserbrief zu DMW 51-52/2003
Dtsch Med Wochenschr 129: 837-838 (2004)
(in German language) 
your personal reprint

Silber S
Which parameter should be chosen as primary endpoint for randomized drug-eluting stent studies?
J Interv Cardiol. 17:375-385, (2004)
your personal reprint

Salvador MJ, Sebaoun A, Sonntag F, Blanch P, Silber S, Aznar J, Komajda M.
European Study of Ambulatory Management of Heart Failure by Cardiologists
Rev Esp Cardiol, 57:1170-1178, (2004)
your personal reprint in Englisch
your personal reprint in Spanisch

Silber S
[Heart failure--yes or no? The third heart sound and markers point the way]
Herzinsuffizienz oder nicht? Dritter Herzton und Marker weisen den Weg
MMW, Fortschr Med. 146: 29 (2004)
(in German language) 
your personal reprint

Vogt A, Albrecht A, Breithardt G, Brennecke R, Fetsch T, Hamm CW, Haude M, Leuner C, Schneider S, Silber S, Zeymer U
[Position Paper of the German Society of Cardiology for Quality Assurance in Interventional Cardiology: Are Minimum Volumes fpr PCI Evidence-Based ?]
Positionspapier zur Qualitätssicherung in der invasiven Kardiologie Sind Mindestmengen bei perkutaner Koronarangioplastie evidenzbasiert?
Z Kardiol 93:829-833, (2004)
(in German language) 
your personal reprint

Grube E, Lansky A, Hauptmann KE, Di Mario C, Di Sciascio G, Colombo A, Silber S, Stumpf J, Reifart N, Fajadet J, Marzocchi A, Schofer J, Dumas P, Hoffmann R, Guagliumi G, Pitney M, Russell ME
SCORE randomized trial. High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization: one-year results from the SCORE randomized trial.
J Am Coll Cardiol, 44:1368-1372, (2004)
your personal reprint

Finsterer S, Nentwich D, Silber S
[The value of BNP determination in general practice]
Stellenwert der BNP-Bestimmung in der Hausarztpraxis
MMW-Fortschr. Med. 146: 750-754, (2004)
(in German language) 
your personal reprint

Silber S
[When are drug-eluting stents effective? A critical analysis of the presently available data]
Wann sind Drug-eluting Stents als wirksam zu bezeichnen?
Eine kritische Analyse der aktuellen Datenlage
Z Kardiol, 93: 649-663, (2004)
(in German language) 
your personal reprint

Lochow P, Silber S
[Immediate hemostasis of the femoral artery after heart catheterization: the present situation of closure systems]
Sofortige Blutstillung der Arteria femoralis nach Herzkatheter: aktueller Stand der Verschlusssysteme.
Dtsch Med Wochenschr, 129:1753-1758, (2004)
(in German language) 
your personal reprint

Böhler S, Glaesmer H, Pittrow D, Lehnert H, Stalla GK, Zeiher AM, Marz W, Silber S, Wehling M, Ruf G, Reinecke A, Wittchen HU.
Diabetes and cardiovascular risk evaluation and management in primary care: progress and unresolved issues - rationale for a nationwide primary care project in Germany.
Exp Clin Endocrinol Diabetes, 112:157-170, (2004)
your personal reprint

Albiero R, Silber S, Di Mario C, Cernigliaro C, Battaglia S, Reimers B, Frasheri A, Klauss V, Auge JM, Rubartelli P, Morice MC, Cremonesi A, Schofer J, Bortone A, Colombo A.
Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT).
J Am Coll Cardiol, 43: 943-949, (2004)
your personal reprint

Reifart N, Morice MC, Silber S, Benit E, Hauptmann KE, de Sousa E, Webb J, Kaul U, Chan C, Thuesen L, Guagliumi G, Cobaugh M, Dawkins K.
The NUGGET study: NIR ultra gold-gilded equivalency trial.
Catheter Cardiovasc Interv:18-25, (2004)
your personal reprint

Mudra H, Bode C, Grube E, de Haan F, Levenson B, Schuler G, Silber S
[Position paper of the German Society of Cardiology on the use of drug eluting stents in coronary heart disease].
Positionspapier zum Einsatz von Medikamente freisetzenden Stents bei Patienten mit koronarer Herzerkrankung.
Leitlinien und Empfehlungen der Deutschen Gesellschaft für Kardiologie
Z Kardiol, 93:416-422, (2004)
(in German language) 
your personal reprint

Silber S, Hamburger J, Grube E, Pfisterer M, Belardi J, Webb J, Zmudka K, Nienaber C, Hauptman K, Rutsch W, Dawkins K, Drzewiecki J, Koglin J, Colombo A.
Direct stenting with TAXUS stents seems to be as safe and effective as with predilatation. A post hoc analysis of TAXUS II.
Herz, 29:171-180, (2004)
your personal reprint

Silber S, Tourlakidou S, Stoeter M, Stalleicken D, Schneider HT:
[The PETN-Study to Evaaluate Nitrate Tolerance in a Double-Blind Protocol with Two Dosages]
Die PETN-Studie (Pentaerythrityltetranitrat Evaluierung der Toleranzentwicklung mit Nitraten): ein doppelblinder, plazebokontrollierter Vergleich zweier Dosierungen.
Perfusion, 17: 236-244, (2004)
(in German language) 
your personal reprint

Naber CK, Baumgart D, Bonan R, Wegscheider K, Serruys PW, Colombo A, Silber S, Eeckhout E, Eggebrecht H, Erbel R, Urban P.
Intracoronary Brachytherapy, a Promising Treatment Option for Diabetic Patients: Results from a European Multicenter Registry (RENO)
Catheter Cardiovasc Interv, 61:173-178, (2004)
your personal reprint

Schofer J, Bode C, Silber S
Drug-Eluting Stents for In-Stent Restenosis and Acute Myocardial Infarction Present Data from Nonrandomized Studies
Herz, 29:195-200, (2004)
your personal reprint

Baumgart D, Bonan R, Naber C, Serruys P, Colombo A, Silber S, Eeckhout E, Urban P.
Successful Reduction if In-Stent Restenosis in Long Lesions using Beta-Radiation: a subanalysis from the RENO Registry.
Int. J. Radiation Oncology Biol. Phys., 58: .817-827, (2004)
your personal reprint

Silber S, Mahn M,
[Secondary Prophylaxis with Clopidogrel in Patients with Clinically Manifest Atherothrombosis in Everyday General Practice]
Sekundärprophylaxe mit Clopidogrel bei Patienten mit klinisch manifester Atherothrombose in der täglichen hausärztlichen Praxis.
Eine Analyse von 8430 Patienten
Perfusion, 17: 178-184, (2004)
(in German language) 
your personal reprint

De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Manger Cats V, Orth-Gomer K, Perk J, Pyorala K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsen T, Wood D;
Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice Executive Summary
Eur Heart J, 24:1601-1610, (2003)
your personal reprint - Executive Summary
Eur J Cardiovasc Prev Rehabil, 10: S1-S10, (2003)
your personal reprint - Full Version

Silber S
Paclitaxel-eluting stents: are they all equal?
An analysis of six randomized controlled trials in de novo lesions of 3,319 patients.
J Interv Cardiol, 16:485-490, (2003)
your personal reprint

Achenbach S, Schmermund A, Erbel R, Silber S, Haberl R, Moshage W, Daniel WG.
[Detection of coronary calcifications by electron beam tomography and multislice spiral CT: clinical relevance]
Klinische Bedeutung des quantitativen Nachweises von Koronarkalk mit Elektronenstrahltomographie (EBT) und Mehrzeilen-Spiral Computertomographie (MSCT)
Z Kardiol, 92:899-907, (2003)
(in German language) 
your personal reprint

Suntharalingam M, Laskey WK, Tantibhedhyangkul W, Lansky A, Teirstein P, Bass T, Silber S, Rutherford B, Wilmer C, Popma JJ, Kuntz R, Bonan R.
Vascular brachytherapy using a beta emitter source in diabetic patients with in-stent restenosis: angiographic and clinical outcomes
Int J Radiat Oncol, 57: 536-542, (2003)
your personal reprint

Urban P, Serruys P, Baumgart D, Colombo A, Silber S, Eeckhout E, Gershlick A, Wegscheider K, Verhees L, Bonan R.
A multicentre European registry of intraluminal coronary beta brachytherapy: RENO
Eur Heart J, 24:604-612, (2003)
your personal reprint

Roguelov C, Eeckhout E, De Benedetti E, Coucke P, Silber S, Baumgart D, Albiero R, Bonan R, Wegscheider K, Urban P; RENO Registry Investigators.
Clinical Outcome Following Combination of Cutting Balloon Angioplasty and Coronary ß-Radiation for In-Stent Restenosis: A Report From the RENO Registry
J Invasive Cardiol, 15: 706-709, (2003)
your personal reprint

Silber S, Grube E, Marco J, Grollier G, Morice MC, Serruys P, Cobaugh M, Wijns W.
Direct stent implantation using the Express Coronary Stent System: results of a multi-center feasibility study
J Interv Cardiol, 16: 491-497, (2003)
your personal reprint

Silber S, Vetter S, Regourd E, Lilienthal J, Ruf G.
[Application and Safety Profile of Quinapril and Quinapril / HCT for the Treatment of Patients with Arterial Hypertension and/or Heart Failure]
Anwendungs- und Sicherheitsprofil von Quinapril und Quinapril/Hydrochlorothiazid bei der Behandlung von Patienten mit Hypertonie und/oder Herzinsuffizienz
Ergebnisse einer gepoolten Analyse mit 109.364 Patienten aus 11 Studien
Perfusion, 16:437-444, (2003)
(in German language) 
your personal reprint

Levenson B, Albrecht A, Gohring S, Haerer W, Herholz H, Kaltenbach M, Reifart N, Sauer G, Silber S, Troger B
 [4th report of German Association of Cardiologists in private practice (BNK) on quality assurance in cardiac catheterization and coronary intervention 1999-2002]
4. Bericht des Bundesverbandes Niedergelassener Kardiologen zur Qualitätssicherung in der diagnostischen und therapeutischen Invasivkardiologie 1999-2002
Herz, 28:335-347, (2003)
(in German language) 
your personal reprint

Oakley C, Child A, Jung B, Presbitero B, Tornos P, Klein W, Garcia MAA, Blomstrom-Lundqvist C, de Backer G, Dargie H, Deckers J, Flather M, Hradek J, Mazotta G, Oto A, Parkhomenko A, Silber S, Torbicki A, Trappe H-J, Dean V, Poumeyrol-Jumeau D
Expert consensus document on management of cardiovascular diseases during pregnancy
Europ Heart J, 24, 761-781, (2003)
your personal reprint

Silber S
[Early detection of myocardial infarct risk with cardio-CT. Can coronary calcium calculation prevention sudden cardiac death?]
Früherkennung des Herzinfarktrisikos mit dem Cardio-CT: Kann die Koronarkalkmessung dem plötzlichen Herztod vorbeugen?
MMW Fortschr Med, 45: 37-40, (2003)
(in German language) 
your personal reprint

Sechtem U, Silber S
[Cardio-MR and cardio-CT: quo vadis?]
Editorial:
Cardio-MR und Cardio-CT: quo vadis ?
Herz, 28:73, (2003)
(in German language) 
your personal reprint

Silber S, Finsterer S, Krischke I, Lochow P, Mühling H.
[Noninvasive angiography of coronary bypass grafts with cardio-CT in a cardiology practice]
Nichtinvasive Angiographie koronarer Bypassgefäße mit dem Cardio-CT in einer kardiologischen Praxis
Herz, 28:126-135, (2003)
(in German language) 
your personal reprint

Schiele TM, Regar E, Silber S, Eeckhout E, Baumgart D, Wijns W, Colombo A, Rutsch W, Meerkin D, Gershlick A, Bonan R, Urban P 
Clinical and angiographic acute and follow up results of intracoronary beta brachytherapy in saphenous vein bypass grafts: a subgroup analysis of the multicentre European registry of intraluminal coronary beta brachytherapy (RENO).
Heart, 89: 640-644, (2003)
your personal reprint

Barry J. Maron, William J. McKenna, Gordon K. Danielsona, Lukas J Kappenberger, Horst J. Kuhn, Christine E. Seidman, Pravin M. Shaha, William H. Spencer IIIa, Paolo Spirito, Folkert J., Ten Catea, E. Douglas Wiglea Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, Shah PM, Spencer WH 3rd, Spirito P, Ten Cate FJ, Wigle ED; ACCF Task Force on Clinical Expert Consensus Documents Members, Vogel RA, Abrams J, Bates ER, Brodie BR, Danias PG, Gregoratos G, Hlatky, MA Hochman JS, Kaul S, Lichtenberg RC, Lindner JR, ORourke RA, Pohost GM, Schofield RS, Tracy CM, Winters Jr WL
ESC Committee for Practice Guidelines Members, Klein WW, Priori SG, Alonso-Garcia A, Blomstrom-Lundqvist C, De Backer G, Deckers J, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A ACC/ESC Expert consensus document American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
Europ Heart J, 24, 1965-1991, (2003)
your personal reprint 
J Am Coll Cardiol, 42:1687-1713, (2003)
your personal reprint

Silber S
[Identification of Patients at Coronary Risk]
Identifizierung koronarer Risikopatienten
Herz, 28: 643-644, (2003)
(in German language) 
your personal reprint

Finsterer S, Silber S
[Heart Failure: The Right Therapy for Weak Hearts]
Kardiale Insuffizienz: Leitlinien für die Hausarztpraxis
Die richtige Therapie für schwache Herzen
Der Hausarzt · 18: 62-66, (2003)
(in German language) 
your personal reprint

Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, Dudek D, Fort S, Schiele F, Zmudka K, Guagliumi G, Russell ME
Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery Lesions - TAXUS-II
Circulation, 108:788-794, (2003)
your personal reprint

Grube E, Silber S, Hauptmann KE, Müller R, Büllesfeld L, Gerckens U, Russell ME,
TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions Circulation, 107:38-42, (2003)
your personal reprint

Silber S
[Off-label use of clopidogrel after coronary stent implantation in Germany: optional or mandatory?]
“Off-Label”-Verschreibung von Clopidogrel nach Stentimplantation: verzichtbar oder zwingend?
Herz, 28:65-71, (2003)
(in German language) 
your personal reprint

Lochow P, Silber S
[Emergencies in the doctor's office. Bleeding from the puncture site after coronary angiography]
Lebensbedrohliche Komplikationen nach Herzkatheter
MMW Fortschr Med, 20;145:40-42. (2003)
(in German language) 
your personal reprint

Silber S, Haude M.
[Intracoronary Brachytherapy to Prevent Restenosis after PCI]
Intrakoronare Brachytherapie zur Restenoseverhinderung nach perkutanen transluminalen Koronarinterventionen
Medizin im Dialog, 1, 1-6 , (2003)
(in German language) 
your personal reprint

Silber S
[Quantification of coronary artery calcifications in the risk stratification of cardiac events]
Quantifizierung von Koronarkalk zur Risikostratifizierung kardialer Ereignisse
Dtsch Med Wochenschr, 127: 2575-2578, (2002)
(in German language)  
your personal reprint 

Talley D, Silber S, Teirstein P, Rodriguez R, Sanborn T, Feldman T, Ellis S. et al. for the SEAL Trial Study Team 
Assessment of the safety and efficacy of the DUETT vascular hemostasis device: final results of the safe and effective vascular hemostasis (SEAL) trial.
Am Heart J, 143:612-619, (2002) 
your personal reprint 

vom Dahl J, Dietz U, Haager PK, Silber S, Niccoli L, Buettner HJ, Schiele F, Thomas M, Commeau P, Ramsdale DR, Garcia E, Hamm CW, Hoffmann R, Reineke T, Klues HG.
Rotational atherectomy does not reduce recurrent in-stent restenosis: results of the angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis trial (ARTIST)
Circulation,105:583-588, (2002) 
your personal reprint 

Silber S
Comparison of spiral and electron beam tomography in the evaluation of coronary calcification in asymptomatic persons
Letter to the Edotor of the Int J Cardiol, 77:181-188, (2001) 
Int J Cardiol, 82:297-298, (2002)
your personal reprint 

Silber S
[Brachytherapy and "evidence based medicine": we must wait longer for the solution]
Brachytherapie und „Evidence Based Medicine“:
Auf die Lösung muss weiter gewartet werden
Letter to the Edotor of the DMW 17:892 (2002)
Dtsch Med Wochenschr 127: 1966–1968 (2002)
(in German language)  
your personal reprint 

Silber S
[Intracoronary Radiation Therapy in Controlled and Open Clinical Studies with Afterloading-Systems and “Hot Balloons”: Analysis of 6,692 Patients] 
Intrakoronare Strahlentherapie in kontrollierten und offenen Studien mit Afterloading-Systemen und “heißen” Ballonkathetern
Eine Analyse von 6692 Patienten
Herz, 27:30-55, (2002)  
(in German language) 
your personal reprint 

Schmermund A, Erbel R, Silber S
MUNICH Registry Study Group. Multislice Normal Incidence of Coronary Health
Age and gender distribution of coronary artery calcium measured by four-slice computed tomography in 2,030 persons with no symptoms of coronary artery disease.
Am J Cardiol, 90:168-173, (2002)
your personal reprint

Serruys PW, Sianos G, van der Giessen W, Bonnier HJ, Urban P, Wijns W, Benit E, Vandormael M, Dorr R, Disco C, Debbas N, Silber S
Intracoronary beta-radiation to reduce restenosis after balloon angioplasty and stenting; the Beta Radiation In Europe (BRIE) study
Eur Heart J, 23:1351-1359, (2002) 
your personal reprint 

Popma JJ, Suntharalingam M, Lansky AJ, Heuser RR, Speiser B, Teirstein PS, Massullo V, Bass T, Henderson R, Silber S, von Rottkay P, Bonan R, Ho KK, Osattin A, Kuntz RE
Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis.
Circulation, 106:1090-1096 (2002)
your personal reprint

Hoffmann R, Herrmann G, Silber S, Braun P, Werner GS, Hennen B, Rupprecht H, vom Dahl J, Hanrath P
IMPact Upon Long Lesion StEnting Study Group (IMPULSE) Randomized comparison of success and adverse event rates and cost effectiveness of one long versus two short stents for treatment of long coronary narrowings
Am J Cardiol, 90:460-464, (2002)
your personal reprint

Silber S
[Antiproliferative coated stents and intracoronary brachytherapy: common traits and differences]
Antiproliferativ beschichtete Stents und intrakoronare Brachytherapie: Gemeinsamkeiten und Unterschiede
Z Kardiol, 91:443-457, (2002)  
(in German language) 
your personal reprint 

Drexler C,Silber S
[The Way to Approval and the Laws for Brachytherapy in the Cath Lab]
Der Weg zur Genehmigung und gesetzliche Vorschriften für die Brachytherapie im Herzkatheterlabor
Book Chapter in: “Kardiovaskuläre Strahlentherapie” Hrsg. C. Hehrlein, 2. Auflage, Steinkopff Verlag, Darmstadt, 87-104, (2002) 
(in German language) 
your personal reprint 

Silber S
[Intracoronary Afterloading with the Novoste-System]
Intrakoronares Afterloading mit dem Novoste-System
Book Chapter in: “Kardiovaskuläre Strahlentherapie” Hrsg. C. Hehrlein, 2. Auflage, Steinkopff Verlag, Darmstadt, 151-167, (2002)
(in German language) 
your personal reprint 

Silber S, Baumgart D, Hehrlein C, Meinertz T, Mügge A, Rutsch W, vom Dahl J. 
The IST Registry
Z Kardiol, 91: Suppl 3:33-39, (2002) 
your personal reprint 

Dietz R, Silber S, Baumgart D, Hehrlein C, Tebbe U.
 [Position paper of the German Society of Cardiology on intracoronary brachytherapy].
Positionspapier der Deutschen Gesellschaft für Kardiologie zur Intrakoronaren Brachytherapie
Z Kardiol: 90, 875-880, (2001) 
(in German language) 
your personal reprint 

Silber S und Grube G.
The BOSTON SCIENTIFIC Antiproliferative, PACLITAXEL eluting stents (TAXUS)
Book Chapter in: Handbook of Coronary Stents, 4th Edition, Editors: P. Serruys and M. Kutryk, Martin Dunitz Publishers LtD, 311-319, (2001)
your personal reprint 

Silber S, Grube G und Fitzgerald P
The QUANAM QUADDS-QP2 Stent
Book Chapter in: Handbook of Coronary Stents, 4th edition, Editors: P. Serruys and M. Kutryk, Martin Dunitz Publishers LtD, 343-347, (2001)
your personal reprint 

Fuster V, Ryden LE, Asinger RW, Cannom DS, Crijns HJ, Frye RL, Halperin JL, Kay GN, Klein WW, Levy S, McNamara RL, Prystowsky EN, Wann LS, Wyse DG, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC, Klein WW, Alonso-Garcia A, Blomstrom-Lundqvist C, De Backer G, Flather M, Hradec J, Oto A, Parkhomenko A, Silber S, Torbicki A.
ACC/AHA/ESC Guidelines for the Management of Patients with Atrial Fibrillation
A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology
European Heart Journal, 22: 1852-1923, (2001)  
your personal reprint - Full Version
J Am Coll Cardiol 38: 1266i-1266lxx, (2001) 
your personal reprint- Fuill Version
J Am Coll Cardiol 38: 1231-1265, (2001) 
your personal reprint - Short Version
Circulation 104: 2118-2150, (2001)  
your personal reprint - Short Version

Silber S for the MUNICH Registry:
[Importance of ECG-triggering with the multi-slice CT for ruling out coronary calcification in individuals without diagnosed coronary disease]
Bedeutung der EKG-Triggerung mit dem Multi-Slice-CT zum Ausschluss einer Koronararterienverkalkung bei Personen ohne bekannte KHK
Herz 26: 260-272, (2001) 
(in German language) 
your personal reprint 

Silber S
[Agatston score and noninvasive coronary angiography: substitute for the heart catheter?]
Agatston-Score und nichtinvasive Koronarangiographie: Ersatz für den Herzkatheter ?
MMW-Fortschritte der Medizin, 143: 25-26, (2001) 
(in German language) 
your personal reprint 

Silber S
[2d Report on increasing volume of diagnostic and interventional heart catheterization in hospitals and private practice in Germany 1990-1999]
2. Bericht über die Mengenzunahme diagnostischer und interventioneller Herzkatheter im krankenhausärztlichen und vertragsärztlichen Bereich in Deutschland 1990-1999
Herz 26: 161-165, (2001) 
(in German language) 
your personal reprint 
 

Silber S, Krischke I, Prohaska M
[Undertreatment in secondary prevention of patients with coronary heart disease after revascularization]
Unterversorgung in der Sekundärprävention bei Patienten mit koronarer Herzerkrankung nach Revaskularisation
Herz, 25: 623 - 626, (2000) 
(in German language) 
your personal reprint 

Silber S
[Necessity of New Noninvasive Diagnostic Procedures to assess the Wall of Coronary Arteries]
Notwendigkeit neuer nichtinvasiver diagnostischer Verfahren zur Beurteilung der Koronararterienwand.
Book Chapter in: Aktuelle Trends in der invasiven Kardiologie Editors: R. Bach u. S. Spitzer, AKA-Verlag, Berlin, 84-102, (2000)
(in German language) 
your personal reprint 

Silber S
The MSM-BMS Coronary Stent
Book Chapter in: Handbook of Coronary Stents, 3rd Edition, Editors: P. Serruys and M. Kutryk, Martin Dunitz Publishers LtD, 147 -151, (2000)
(in German language) 
your personal reprint

Dörr R, Silber S
[Methods of Physical and Pharmacological Stress for Myocardial Scintigraphy]
Methodik der ergometrischen und pharmakologischen Belastung für die Myokardszintigraphie.
in: Nuklearmedizin 2000, Editors: N. Avril und A. Tausig, Tagungsband der gemeinsamen Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Nuklearmedizin, 121-126, (2000)
(in German language) 
your personal reprint 

Silber S
[Therapy of Heart Failure - Lessons Learned from Recent Trials]
Therapie der Herzinsuffizienz - Die Lehren aus den jüngsten Studien
MMW-Fortschr.Med. 142: 25, (2000) 
(in German language) 
your personal reprint 

Silber S
[The Way to Obtain Approval for Clinical Studies and Routine Administration of Intracoronary Brachytherapy in the Catheterization Laboratory]
Der Weg zur Genehmigung für klinische Studien und für die Routineanwendung der intrakoronaren Brachytherapie im Herzkatheterlabor.
Book Chapter in: Kardiovaskuläre Strahlentherapie - ein multidisziplinäres Lehrbuch Editors: Chr. Hehrlein, Dr. Dietrich SteinkopffVerlag, 73-88, (2000) 
(in German language) 
your personal reprint 

Silber S 
[10 years of arterial closure devices: a critical analysis of their use after PTCA]
10 Jahre arterielle Verschlußsysteme: Eine kritische Analyse ihrer Anwendung nach PTCA.
Zeitschrift für Kardiologie 89. 383-389, (2000) 
(in German language) 
your personal reprint 

Silber S
[Risk stratification in acute coronary syndrome. Practical procedure depends on severity]
Risikostratifizierung bei akutem Koronarsyndrom.
MMW-Fortschr.Med. 18: 33-34, (2000) 
(in German language) 
your personal reprint 

Silber S
[Coronary Interventions: What's New ?]
Koronarinterventionen: Was gibt es Neues ?
Kardiologie Assistenz 12: 10-13, (2000) 
(in German language) 
your personal reprint 

Silber S, Levenson B, Schräder R, Kaltenbach M
[Second and Third Annual Report of the German Society of Coronary Angiography and Interventions in Private Practice (BNK) concerning quality assurance in invasive cardiology]
Zweiter und dritter Jahresbericht des BNK zur Qualitätssicherung in der Invasivkardiologie ("QUIK")
Herz 25: 143-150, (2000
(in German language)
your personal reprint 

Silber S, von Rottkay P, Lossl P, Schneider A, Seidel N, Tourlakidou S, Krischke I, Gessler B, Naser K, Bauer A
[Safety and feasibility of intracoronary brachytherapy with the Novoste system within the scope of international multicenter studies]
Sicherheit und Durchführbarkeit der intrakoronaren Brachytherapie mit dem Novoste™-System im Rahmen von internationalen Multicenter-Studien
Z Kardiol: 89, 323-329, (2000)  
(in German language) 
your personal reprint 

Silber S
[Double-blind, Placebo-controlled Pilot Study to Assess the Efficacy of a once-daily administration of Pentaerithrityltetranitrate (PETN) as compared to a t.i.d.regimen in Patients with Stable Angina Pectoris]
Doppelblinde, plazebokontrollierte Pilotstudie zur Wirksamkeit einer 1xtäglichen Gabe von Pentaerithrityltetranitrat (PETN) im Vergleich zur 3xtäglichen Gabe bei Patienten mit stabiler Angina pectoris
Book Chapter in:
Pentaerithrityltetranitrat: Pharmakologische und klinische Daten zur Koronaren Herzkrankheit
Editors: E. Mutschler und K. Schrör
ISBN 3.7985.1197.7 Steinkopff Verlag, Darmstadt
61-71 (1999) 
(in German language) 
your personal reprint 

Silber S
Management of Vascular Sheath Following PTCA:
Vascular Closure Devices for Immediate Sheath Removal after Coronary Interventions:
Luxury or Necessity ?
Book Chapter in:
Strategic Approaches in Coronary Intervention,
Stephen G. Ellis and David R. Holmes, Editors
Lippincott Wiliams & Wilkins, Philadelphia, second edition,
ISBN 0-683-30729-0
452-460 (1999)
your personal reprint​

Silber S
[Intracoronary brachytherapy after PTCA: current clinical position]
Intrakoronare Brachytherapie nach PTCA: aktueller klinischer Stand.
Dtsch. med. Wschr. 124: 1491-1495, (1999) 
(in German language) 
your personal reprint 

Silber S, Schneider A:
Introduction of Brachytherapy to a German Catheterization Laboratory: How to meet the Regulations within a Reasonable time Frame.
J Interven Cardiol 12: 473-476, (1999) 
your personal reprint 

Silber S, Tofte AJ, Kjellevand TO, Grube E, Gershony G:
Final Report of the European Multi-center Registry using the Duett™ Vascular Sealing Device.
Herz 24: 620 - 623, (1999) 
your personal reprint 

Silber S
[Increasing Volumes of Diagnostic and Interventional Cardiac Catheterizations in Hospital- and Office-Based Cath Labs in Germany]
Mengenzunahme diagnostischer und interventioneller Herzkatheter im krankenhausärztlichen und vertragsärztlichen Bereich in Deutschland.
Herz 24: 347-350, (1999) 
(in German language) 
your personal reprint 

Silber S, Gershony G, Schön B, Schön N, Jensen T, Schramm W:
A Novel Vascular Sealing Device for Closure of Percutaneous Arterial Access Sites.
Am J Cardiol 83: 1248-1252, (1999) 
your personal reprint 

Silber S, v. Rottkay P, Gielow A, Schneider A, Bauer A, Schöfer H
[Intracoronary brachytherapy with strontium/yttrium-90. Initial experiences in Germany]
Intrakoronare Brachytherapie mit Strontium/Yttrium-90: erste Erfahrungen in Deutschland
Herz 23: 380-393, (1998) 
(in German language) 
your personal reprint 

Silber S
[Restenosis and Intracoronary Radiation]
Restenose und intrakoronare Bestrahlung.
Book Chapter in: Aktuelle Trends in der invasiven Kardiologie Editors: R. Bach u. S. Spitzer, AKA-Verlag, 101- 110, (1998)
(in German language) 
your personal reprint 

Silber S, Björvik A, Mühling H, Rösch A:
Usefulness of Collagen Plugging with VasoSeal® as Compared to Manual Compression with Identical Sheath Dwell Times.
Cath Cardiovasc Diagn 43: 421-427, (1998) 
your personal reprint 

S. Silber, Albrecht A, Göhring S, Kaltenbach M, Kneissl D, Kokott N, Levenson B, Mathey D, Pöhler E, Reifart N, Sauer G, Schofer J, Schwarzbach F
[First annual report of practitioners of interventional cardiology in private practice in Germany. Results of procedures of left heart catheterization and coronary interventions in the year 1996]
Erster Jahresbericht niedergelassener Invasivkardiologen in Deutschland: Ergebnisse für diagnostische Linksherzkatheteruntersuchungen und Koronarinterventionen 1996 ("QUIK")
Herz, 23: 47-57, (1998) 
(in German language) 
your personal reprint 

Silber S, Schön N, Seidel N, Heiß-Bogner J
[Accidental occlusion of the common femoral artery after Angio-Seal-application]
Akzidenteller Verschluß einer A. femoralis communis nach Angio-Seal-Applikation.
Z Kardiol 87: 51-55, )1998) 
(in German language) 
your personal reprint 

Silber S
Hemostasis Success Rates and Local Complications Using Collagen after Femoral Access for Cardiac Catheterization: Analysis of 6007 Published Patients.
Am Heart Journal 135: 152-156, (1998) 
your personal reprint 

Silber S
Rapid Hemostasis of Arterial Puncture Sites with Collagen: Time to Hemostasis, Time to Ambulation and Minor/Major Local Complication Rates in Patients Undergoing Diagnostic and Interventioal Cardiac Catheterization.
Clin Cardiol 20:981-992, (1997) 
your personal reprint 

Silber S, Dörr R, Zindler G, Mühling H, Diebel T
Impact of various compression rates on interpretation of digital coronary angiograms.
Int J Cardiol 60: 195-200, (1997) 
your personal reprint 

Silber S, Dörr R, Mühling H, König U:
Sheath Pulling Immediately After PTCA: Comparison of Two Different Deployment Techniques for the Hemostatic Puncture Closure Device: A Prospective, Randomized Study.
Cathet Cardiovasc Diagn 41: 378-383, (1997) 
your personal reprint 

Silber S
[NMR - Basics of Nuclear Magnetic Resonance in Cardiology]
NMR - Grundzüge der Kernspintomographie in der Kardiologie
Book Chapter in: Kardiovaskuläre Nuklearmedizin, Editors: G Hör, BJ Krause HH Tillmanns, Ecomed Verlag Landsberg, 347-364, (1997) 
(in German language) 
your personal reprint 

Silber S
Compendium - Angina Pectoris
Leitfaden - Angina pectoris.
Medizin im Bild 3/1997, 43-44, (1997)
(in German language)  
your personal reprint 

Silber S, Mühling H, Dörr R, Zindler G, Preuss A, Stümpfl A
[Waiting times and death on the waiting list for coronary artery bypass operation. Experiences in Munich with over 1,000 patients]
Wartezeiten und Tod auf der Warteliste für eine koronare Bypassoperation. Erfahrungen in München an über 1000 Patienten.
Herz, 21: 389-396, (1996) 
(in German language) 
your personal reprint 

Silber S
[Quality assurance in cardiology: Germany]
Qualitätssicherung in der Kardiologie
Herz 21: 273-282, (1996)
(in German language) 
your personal reprint 

Silber S
[Stress echocardiography versus myocardial scintigraphy: comparative value in coronary heart disease]
Streßechokardiographie versus Myokardszintigraphie: Vergleichende Wertigkeit bei koronarer Herzerkrankung
Herz, 21: 136-141, (1996) 
(in German language) 
your personal reprint 

Silber S
[Characteristics of angina pectoris therapy with nitrates]
Besonderheiten der Angina-pectoris-Therapie mit Nitraten
Herz, 21: Suppl I, 4-21, (1996) 
(in German language) 
your personal reprint 

Silber S, Dörr R
[Differential antithrombotic therapy in patients with low and high PTCA risk]
Differenzierte antithrombotische Therapie bei Patienten mit niedrigem und hohem PTCA-Risiko
Herz, 21: 44-56, (1996) 
(in German language) 
your personal reprint 

Silber S
[What do Calcium-Antagonists Achieve ?]
Was leisten Kalziumantagonisten ?
Münchner Medizinische Wochenschrift, 136: 10, (1994)
(in German language) 
your personal reprint​
 

Silber S
Rational Therapy with Nitrates: Commitment to a high dosage once-daily regimen.
Book Chapter in
“Nitrate therapy and Nitrate Tolerance” - Current concepts. Editor.: D. Rezakovic u. J.S. Alpert Karger Verlag Basel, 397-442, (1993)
your personal reprint​

The Cardiac Arrhythmia Supression Trial:
The CAST II Investigators*
*Sigmund Silber, MD
Effect of the Antiarrhytmic Agent Moricizine on Survival after Myocardial Infarction.
New Engl J Med, 327: 227-233, (1991) 
your personal reprint 

Silber S
[Calcium Antagonists after Myocardial Infarction - What is known ?]
Kalziumantagonisten nach Herzinfarkt - Was ist gesichert ?
Münch.med.Wschr. 133, 587-588, (1991)
(in German language) 
your personal reprint​

Denes P et al for the the CAST Investigators*
*Sigmund Silber, MD
Prevalence, Characteristics and Significance of Ventricular Premature Complexes and Ventricular Tachycardia Detected by 24-Hour Continuous Electrocardiographic Recording in the Cardiac Arrhythmia Supression Trial.
Am J Cardiol, 68: 887-896, (1991) 
your personal reprint 

Echt DS et al. for the CAST Investigators*
*Sigmund Silber, MD
Mortality and Morbidity in Patients receiving Encainide, Flecainide or Placebo.
New Engl. J. Med 324: 781-788, (1991) 
your personal reprint 

Silber S, Cranney G, Lotan Ch, Elgavish G, Pohost G
[Advances in the Diagnosis of Cardiovascular Diseases with Nuclear Magnetic Resonance (NMR)]
Fortschritte in der Diagnostik kardiovaskulärer Erkrankungen mittels Kernspintomographie (NMR).
Book Chapter In “Kardiologie Aktuell” (Eds. Delius/Sack/Stöckle), Gustav Fischer Verlag, Stuttgart - New York, 41-59, (1990) 
(in German language) 
your personal reprint 

Silber S
[Interval Therapy with Nitrates: Which Strategies are evidence-based ?]
Intervalltherapie mit Nitraten: Welche Strategien sind gesichert ?
Deutsches Ärzteblatt, 34/35: 2560-2562, (1990) 
(in German language) 
your personal reprint 

Silber S
Nitrates: Why and how should they be used today? The current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate
Eur J Clin Pharmacol, 38: 35- 51, (1990) 
your personal reprint 

Silber S, Bajaj RK, Kirk KA, Pohost GM
Accuracy of Digital Holter Monitoring of Extent and Duration of Ischemic Episodes Compared to Analog Recording.
Am J Cardiol, 65: 383-388, (1990) 
your personal reprint 

Canby RC, Silber S, Pohost GM
Relations of the Myocardial Imaging Agents 99mTc-MIBI and 201-Tl to Myocardial Blood Flow in a Canine Model of Myocardial Ischemic Insult.
Circulation, 81: 289-296, (1990) 
your personal reprint 

Silber S
[Editorial:
Nitrates: old, but still up-to-date]
Nitrate: alt, doch stets aktuell
Herz+Gefäße, 9, 607, (1989) 
(in German language) 
your personal reprint 

Vogler AC, Silber S, Spiegelsberger F, Theisen K:
[Extent of therapeutic effect and duration of 1 capsule of 120 mg isosorbide dinitrate in a slow release form]
Wirkungsausmaß und -dauer einer Kapsel 120 mg Isosorbiddinitrat in retardierter Form.
Zeitschrift für Kardiologie, 78, 421-426, (1989) 
(in German language) 
your personal reprint​

Vogler AC, Silber S, Vogel M, Theisen K
[Combination therapy with isosorbide dinitrate and verapamil in patients with coronary heart disease and hypertension: effect on blood pressure, ischemia and left ventricular function]
Kombinationstherapie mit Isosorbiddinitrat und Verapamil bei Patienten mit koronarer Herzerkrankung und Hypertonus: Wirkung auf Blutdruck, Ischämie und linksventrikuläre Funktion.
Zeitschrift für Kardiologie 78: Suppl. 2, 183 - 187, (1989) 
(in German language) 
your personal reprint 

Silber S
[Combination of anti-angina drugs]
Kombination antianginöser Medikamente
Zeitschrift für Kardiologie, 78: Suppl. 2, 160-174, (1989) 
(in German language) 
your personal reprint 

Silber S
[Prevention of myocardial infarction with nitrates, beta blockers and calcium antagonists]
Prävention des Myokardinfarktes mit Nitraten, Betablockern und Kalziumantagonisten
Der Internist, 30, 322-330, (1989) 
(in German language) 
your personal reprint 

Silber S
[Coronary Insufficiency: Importance of Noninvasive Tests and Coronary Angiography for the Assessment of the Cardiac Risk]
Koronarinsuffizienz: Bedeutung nichtinvasiver Untersuchungsmethoden und der Koronararteriographie für die Abschätzung des kardialen Risikos.
Book Chapter in:
“Das kardiale Risiko” (Eds. H Jahrmärker, K Theisen, H Holzgartner), AMV, AVKommunikation und Medizin Verlag München, 3562, (1989)
(in German language) 
your personal reprint 

Silber S, Vogler AC, Spiegelsberger F, Vogel M, Theisen K
Validation of digital Holter ST-segment analysis
J Ambulatory Monitoring 1:1451-1452, (1988) 
your personal reprint 

Silber S, Vogler AC, Spiegelsberger F, Vogel M, Theisen K
The insufficient nitrate response: Patients” characterization and response to beta and calcium blockade
Europ Heart J 9 (Suppl. A):125-134, (1988) 
your personal reprint 

Silber S, Vogler AC, Spiegelsberger F, Vogel M, Theisen K
Antiischemic Effects of a Newly Developed Capsule Containing 120 mg Isosorbide Dinitrate in Sustained Release Form
Am J Cardiol 61:1352-1353, (1988) 
your personal reprint 

Silber S
[Current Status of the Therapy with Orally Applied Nitrates]
Aktueller Stand der Therapie mit oral applizierten Nitraten
Der Praktische Arzt - Österreichische Zeitschrift für Allgemeinmedizin
1079-1086 (1987)
(in German language) 
your personal reprint​

Silber S, Vogler AC, Krause KH, Vogel M, Theisen K
Induction and circumvention of nitrate tolerance applying different dosage intervals
Am J Med 83:860-870, (1987) 
your personal reprint 

Silber S, Vogler AC, Krause KH, Theisen K
A single tablet of 80 mg isosorbide dinitrate in slow release form: characterization of its hemodynamic and antiischemic effects
Drugs, 33 (Suppl. 4):69-79, (1987) 
your personal reprint 

Silber S
[Silent Myocardial Ischemia: Practical Consequences]
Stumme Myokardischämie: Konsequenzen für Klinik und Praxis
Münchener Medizinische Wochenschrift, 129, 16-18, (1987)
(in German language) 
your personal reprint​

Silber S
[Is it Possible to Prolong the Life of Patients with Coronary Artery Disease ?]
Kann das Leben von Patienten mit koronarer Herzerkrankung verlängert werden?
Deutsches Ärzteblatt; 83: 2084-2090 (1986)
(in German language)
your personal reprint 

Letter to the Editor and Final Remarks:
Deutsches Ärzteblatt; 83: 3300 (1986) 
(in German language) 
your personal reprint 

Theisen K, Angermann Ch, Silber S, Weber M
[Superfluous cardiologic diagnosis]
Überflüssige kardiologische Diagnostik
Internist, 27, 552-565, (1986)
(in German language) 
your personal reprint​

Silber S, Vogler A, Theisen K
[Value of Exercise-ECG and Myocardial Scintigraphy for Diagnosis and Prognostic Assessment of Coronary Artery Disease]
Stellenwert von Belastungs-EKG und Herzszintigraphie zur Diagnostik und prognostischen Beurteilung einer koronaren Herzerkrankung
Der Bayerische Internist, 6-16, (1986)
(in German language) 
your personal reprint​

Silber S, Vogler A, Theisen K
Equal antiischemic properties of isosorbide dinitrate plus verapamil and isosorbide dinitrate plus propranolol. A randomized, doubleblind and crossover study
Zeitschrift für Kardiologie, 75, Suppl. 3, 100-105, (1986) 
your personal reprint 

Silber S, Vogler A:
[Silent Myocardial Ischemia: Dimensions of a Problem]
Die stumme Myokardischämie: Dimensionierung eines Problems
Intensivmedizin, 23, 52-63, (1986) 
(in German language) 
your personal reprint 

Silber S, Hany F, Weber M, Theisen K, Jahrmärker H
[Effects of the Selective Alpha-1-Blocker Urapidil on the Hemodynamics of Patients with Chronic Heart Failure without Arterial Hypertension]
Wirkung des selektiven Alpha-1-blockers Urapidil auf die Hämodynamik von Patienten mit chronischer Herzinsuffizienz ohne arterielle Hypertonie
Book Chapter in: “Vasoaktive Substanzen bei Herzinsuffizienz” (Eds. WD Bussman, H Just). SpringerVerlag, Berlin, Heidelberg, S. 101-111, (1986)
(in German language) 
your personal reprint 

Silber S
 [When is a patient with coronary heart disease optimally treated?]
Wann ist ein Patient mit koronarer Herzerkrankung optimal behandelt?
Internist, 27, 525-540, (1986) 
(in German language) 
your personal reprint 

Silber S
[Nitrate Therapy:
High or Low Plasma Levels ?
Sustained or Unsustained Releases ?
Consequences of lacking a 24 hours Protection]
Nitrat-Therapie:
Hohe oder niedrige Plasmaspiegel ?
Retardierte oder unretardierte Präparate ?
Konsequenzen des fehlenden 24-Stundenschutzes
Herz+Gefäße, 6, 372-380, (1986)
(in German language) 
your personal reprint​

Silber S
[Actual Aspects of Long-Term-Treatment with Orally and Transdermally Applied Nitrates]
Aktuelle Gesichtspunkte der Langzeitbehandlung mit oral und transdermal applizierten Nitraten
Innere Medizin, 13, 26-31, (1986)
(in German language) 
your personal reprint​

Scheininger M, Silber S, Theisen F, Theisen K
[Influence of Amiodarone on Left Verntricular Ejection Fraction in Patients with reduced Ejection Fraction and Complex Arrhythmias]
Einfluß von Amiodaron auf die linksventrikuläre Auswurffraktion bei Patienten mit eingeschränkter Auswurffraktion und komplexen Rhythmusstörungen
Intensivmedizin, 23, 74-78, (1986)
(in German language) 
your personal reprint​

Silber S
Letter to the Editor:
[Delayed-action nitrate forms]
Leserzuschrift:
Retardierte Nitratformen
Deutsche Medizinische Wochenschrift, 110, 776-778, (1985) 
(in German language) 
your personal reprint 

Silber S
Clinical relevance of nitrate tolerance
Boo Chapter in: `Mononitrates” (Eds. JN Cohn, R Rittinghausen). SpringerVerlag, Berlin, Heidelberg, 130-146, (1985)
your personal reprint​

Silber S
Can the problem of nitrate tolerance be solved?
Zeitschrift für Kardiologie, 74, Suppl. 1, 51-54, (1985)
your personal reprint​

Silber S, Krause KH, Garner Ch, Theisen K
[Do we have to Modify the Guidelines for Long-Term Therapy with Nitrates ?]
Müssen die Richtlinien für die Langzeit-Therapie mit Nitraten bei Patienten mit koronarer Herzerkrankung modifiziert werden?
Verhandlungen der Deutschen Gesellschaft für Innere Medizin, Bergmann Verlag, München, 90,
846-848, (1984)
(in German language) 
your personal reprint 

Silber S, Garner Ch, Kotzur J, Weber M, Haufe M, Theisen K
[Fully Automatic Calculation of Left Ventricular Ejection Fraction with Radionuclide Ventriculography]
Vollautomatische Berechnung der Linksventrikulären Auswurffraktion mit der Radionuklidventrikulographie
Book Chapter in: “Nuklearmedizin, Darstellung von Metabolismus und Organfunktionen” (Eds. H Schmidt, W Adam). Schattauer Verlag, 298-302, (1984)
(in German language) 
your personal reprint​

Silber S
[Diagnosis of Angina Pectoris]
Diagnostik der Angina pectoris
Kolloquium, 2, 21.Woche, (1984)

Silber S
[Editorial:
Oral Long-Term Therapy with Nitrates:
Less Tablets - more Effects
Orale Nitrat-Langzeittherapie:
weniger Tabletten - mehr Wirkung
Münchener Medizinische Wochenschrift, 126, 913-914, (1984)
(in German language) 
your personal reprint​

Silber S
[Nitrate tolerance: pro and con]
Nitrattoleranz: Pro und Contra
Dtsch. Med. Wschr., 28/29, 1124-1132, (1984) 
(in German language) 
your personal reprint 

Silber S
[Value of Exercise ECG]
Stellenwert des BelastungsEKG"s
Diagnostik, 17, 16-23, (1984) 
(in German language) 
your personal reprint 

Feder E, Trenkwalder T, Silber S, Weber M, Lydtin H
[High-Dose Systemic Therapy with Streptokinase for Acute Myocardial Infarction]
Hochdosierte systemische StreptokinaseTherapie bei akutem Herzinfarkt
Münchener Medizinische Wochenschrift, 126, 772-775, (1984) 
(in German language) 
your personal reprint 

Silber S, Krause KH, Garner Ch, Theisen K, Jahrmärker H
Antiischemic effects of an 80 mg tablet of isosorbide dinitrate in sustained release form before and after 2 weeks treatment with 80 mg once or twice daily
Zeitschrift für Kardiologie, 72, Suppl. 3, 211-217, (1983) 
your personal reprint 

Silber S
[Possibilities and Limitations of Radionuclide Ventriculography for the Assessment of Pharmacological Interventions, e.g. with Nifedipin]
Möglichkeiten und Grenzen der Radionuklidventrikulographie zur Beurteilung pharmakologischer Interventionen, z.B. mit Nifedipin
Book Chapter in:
“Erfahrungen mit Adalat in Klinik und Praxis” (Ed. HJ Just). OttoVerlag Bamberg, 27-36, (1983)
(in German language) 
your personal reprint​

Silber S, Schwaiger M, Hall D, Klein U, Rudolph W
Value of the radialsegmental ejection fraction in the assessment of regional left ventricular function in the radionuclide ventriculogram.
Book Chapter in:
“Noninvasive Assessment of the Cardiovascular System”, Diagnostic Principles and Techniques (Eds. EB Diethrich, J Wright). PSG Inc., 199-203, (1982) 
your personal reprint 

Silber S, Schwaiger M, Klein U, Rudolph W. 
[Tomographic and Planar Myocardial Scintigraphy with 201-Thallium for the Evaluation of the Results after Bypass Surgery]
Tomographische und planare Myokardszintigraphie mit 201Thallium zur Beurteilung der Ergebnisse koronarchirurgischer Revaskularisationsmaßnahmen.
Book Chapter in: “Kardiovaskuläre Nuklearmedizin” (Eds. G Hör, R Felix). Schnetztor Verlag, Konstanz, 99-109, (1981)
(in German language) 
your personal reprint 

Mueller-Schauenburg W, Kaiser W, Feine U, Silber S
[Experiences with an Interactive Assessment of Myocardial Profiles]
Erfahrungen mit einer interaktiven Myokard-Profilauswertung
Book Chapter in:
“Nuklearmedizin im interdisziplinären Bezug” (Eds. HAE Schmidt, F Wolf, J Mahlstedt). Schattauer Verlag, Stuttgart, New York, 79-82, (1981)
(in German language) 
your personal reprint​

Silber S, Schwaiger M, Klein U, Rudolph W.
[Quantitative assessment of global and regional ventricular function with radionuclide ventriculography: determination of global ejection fraction with various calculation methods, analysis of regional ejection fraction with the radial-segmental method]
Quantitative Beurteilung der linksventrikulären Funktion mit der Radionuklidventrikulographie.
Herz, 5, 146-158, (1980)
(in German language) 
your personal reprint 

Silber S, Schwaiger M, Fleck E, Klein U, Rudolph W.
 [The technetium-99-m-pyrophosphate scintigram in the assessment of the size of acute myocardial infarction: comparison with CK-(MB) curves mortality]
Größenbestimmung akuter Myokardinfarkte mit 99mTechnetiumPyrophosphat: Vergleich zu CK(MB)-Verlauf und Letalität.
Herz, 5, 101-106, (1980)
(in German language) 
your personal reprint 

Silber S, Klein U, Rudolph W
 [Value of the 201-thallium scintigram in the diagnosis of coronary artery disease in patients with and without myocardial infarction]
Klinische Bedeutung der 201-ThalliumSzintigraphie für die Diagnostik der koronaren Herzerkrankung bei Patienten mit und ohne Myokardinfarkt.
Der Radiologe, 20, 70-75, (1980)
(in German language) 
your personal reprint

Schwaiger M, Silber S, Klein U, Rudolph W. 
[Myocardial scintigraphy with thallium-201: the current status]
Myokardszintigraphie mit 201-Thallium: Eine Zwischenbilanz
Herz, 5, 79-85, (1980)
(in German language) 
your personal reprint 

Fleck R, Froer KL, Bierner M, Silber S, Rudolph W
[Management of patients with spontaneous angina pectoris]
Diagnostisches und therapeutisches Vorgehen bei Patienten mit spontaner Angina pectoris
Herz, 5, 1-15, (1980) 
(in German language) 
your personal reprint 

Silber S, Fleck E, Klein U, Rudolph W:
[The value of the thallium-201 scintigram as compared with the exercise electrocardiogram in patients with coronary artery disease but no myocardial infarction]
Wertigkeit der 201-Thallium-Belastungsszintigraphie im Vergleich zur Belastungselektrokardiographie bei Patienten mit koronarer Herzerkrankung ohne Myokardinfarkt
Herz, 4, 359-369, (1979) 
(in German language) 
your personal reprint 

Silber S, Fleck D, Bierner M, Klein U, Rudolph W
[Scintigraphic detection of remote transmural myocardial infarction with thallium-201.-Influence of localization, extent and degree of left ventricular asynergy]
Szintigraphischer Nachweis abgelaufener Myokardinfarkte mit 201-Thallium: Einfluß von Lokalisation, Ausdehnung und Schweregrad der linksventrikulären Wandbewegungseinschränkung
Herz, 4, 428-437, (1979) 
(in German language) 
your personal reprint 

Silber S, Rinke H, Klein U, Locher D, Goppel L, Rudolph W
[Value of 201-Thallium Scintigraphy for the Diagnosis of Hypertrophic Cardiomyopathy]
Die Wertigkeit der 201-Thallium Szintigraphie zur Diagnostik der hypertrophen Kardiomyopathie
Book Chapter in:
“Nuklearmedizin und Biokybernetik” (Eds. H Oeff, AHE Schmidt). Medico Verlag Berlin, Band 1, 358-363, (1978)
(in German language) 
your personal reprint

Silber S, Jennerwein G, Goppel L, Locher D, Klein U, Rudolph W
Visualization of the right ventricular free wall in the 201-Thallium scintigram in patients with right ventricular volume overload
Book Chapter in:
“Noninvasive Cardiovascular Diagnosis” Current Concepts (Ed. E Diethrich). University Park Press, Baltimore, 475-481, (1978)
your personal reprint

Rudolph W, Froer KL, Bierner M, Goedel-Meinen L, Silber S, Kraus F, Fleck E, Gehrke A, Eckstein R, Goppel L
[Diagnosis of Coronary Artery Disease]
Diagnostik der koronaren Herzerkrankung
Euromed, 18, 14-26, (1978) 
(in German language) 
your personal reprint 
similar reprint

Klein U, Silber S, Rinke H, Locher D, Goppel L, Rudolph W
[201-Thallium Scintigraphy in Patients with Elevated Right Ventricular Pressures or Volumes] 
201-Thallium-Szintigraphie bei rechtsventrikulärer Druck- und Volumenbelastung
Book Chapter in:
“Nuklearmedizin und Biokybernetik” (Eds. H Oeff, AHE Schmidt). Medico Verlag Berlin, Band 1, 368-373, (1978)
(in German language) 
your personal reprint

Silber S, Klein U, Goppel L, Rinke H, Petri H, Weber M, Rudolph W
201-Thallium myocardial imaging in patients with hypertrophic cardiomyopathy and right ventricular overload
Herz, 2, 176-180, (1977) 
your personal reprint 

Klein U, Locher D, Silber S
[Diagnostic Tests with X-Rays and Nuclear Medicine at the German Heart Center in Munich]
Röntgendiagnostische und nuklearmedizinische Untersuchungen im Deutschen Herzzentrum München
Herz, 1, 108-117, (1976) 
(in German language) 
your personal reprint 

Remien J, Silber S, Felix W
[Increasing Venous Tone by Horse Chestnut Extracts ?]
Venentonisierung durch Rosskastanienextrakte?
Phlebologie und Proktologie, 3, 35-42, (1974)
(in German language) 
your personal reprint